Processing 00000000.tx.1: The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens You-Di Liao*,1, Sui-Chi Wang1, Ying-Jen Leu1,2, Chiu-Feng Wang1, Shu-Ting Chang1, Yu-Ting Hong1, Yun-Ru Pan1 and Chinpan Chen1 1 Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan and 2 Department of Life Sciences, National Tsing-Hua University, Hsin-Chu 300, Taiwan *To whom correspondence should be addressed. 

Phrase: "The structural integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "exerted by N-terminal pyroglutamate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0015264:Exerted [Organism Function]
   760   C0205088:Terminal [Temporal Concept]
   760   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]

Phrase: "is"

Phrase: "crucial for the cytotoxicity of frog ribonuclease"

Phrase: "from Rana pipiens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034653:Rana pipiens [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: "You-Di Liao"

Phrase: "*,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "Sui-Chi Wang1,"

Phrase: "Ying-Jen Leu1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Chiu-Feng Wang1,"

Phrase: "Shu-Ting Chang1,"

Phrase: "Yu-Ting Hong1,"

Phrase: "Yun-Ru Pan1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1427803:PAN1 [Gene or Genome]

Phrase: "and"

Phrase: "Chinpan Chen1 1 Institute of Biomedical Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "Academia Sinica,"

Phrase: "Taipei 115,"

Phrase: "Taiwan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "and"

Phrase: "2 Department of Life Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "National Tsing-Hua University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "Hsin-Chu 300,"

Phrase: "Taiwan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.2: Tel: +886 2 27899167; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+886 2 27899167"

Phrase: ";"
Processing 00000000.tx.3: Fax: +886 2 27829142; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+886 2 27829142"

Phrase: ";"
Processing 00000000.tx.4: Email: ydliao{at}ibms.sinica.edu.tw Received July 7, 2003; 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "ydliao{at}ibms.sinica.edu.tw Received July 7,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0039260:TW [Geographic Area]
   791   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   791   C0332293:TW [Therapeutic or Preventive Procedure]
   791   C1514756:Received [Qualitative Concept]
   758   C0238190:IBM [Disease or Syndrome]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.5: Revised and Accepted August 1, 2003 DDBJ/EMBL/GenBank accession no. 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted August 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003 DDBJ/EMBL/GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1510755:Accession [Intellectual Product]
   804   C1706078:Accession [Activity]

Phrase: "no."
Processing 00000000.tx.6: AF332139.  

Phrase: "AF332139."
Processing 00000000.tx.7: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Onconase, a cytotoxic ribonuclease from Rana pipiens, possesses pyroglutamate (Pyr) at the N-terminus and has a substrate preference for uridineguanine (UG). 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Onconase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "a cytotoxic ribonuclease from Rana pipiens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "pyroglutamate (Pyr) at the N-terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "has"

Phrase: "a substrate preference for uridineguanine (UG)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0558295:preference [Idea or Concept]
   760   C1549513:Preference [Idea or Concept]
Processing 00000000.tx.8: To identify residues responsible for onconases cytotoxicity, we cloned the rpr gene from genomic DNA and expressed it in Escherichia coli BL21(DE3). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "responsible for onconases cytotoxicity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the rpr gene from genomic DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "expressed"

Phrase: "it in Escherichia coli BL21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014834:Escherichia coli [Bacterium]
   760   C0014833:Escherichia [Bacterium]
   760   C0450615:BL21 [Body Location or Region]

Phrase: "(DE3"

Phrase: ")."
Processing 00000000.tx.9: The recombinant onconase with Met at the N-terminus had reduced thermostability, catalytic activity and antigenicity. 

Phrase: "The recombinant onconase with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "Met at the N-terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550543:Meet [Idea or Concept]

Phrase: "had"

Phrase: "reduced thermostability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597571:thermostability [Natural Phenomenon or Process]

Phrase: "catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "antigenicity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2698667:ANTIGENICITY [Regulation or Law]
   900 E C0003320:Antigen [Immunologic Factor]
Processing 00000000.tx.10: Therefore, we developed two methods to produce onconase without Met. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "developed"

Phrase: "two methods to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "produce"

Phrase: "onconase without Met."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.11: One relied on the endogeneous E.coli methionine aminopeptidase and the other relied on the cleavage of a pelB signal peptide. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "relied on the endogeneous E.coli methionine aminopeptidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0014834:E coli [Bacterium]
   770   C0127863:Methionine aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0002570:Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "the other relied on the cleavage of a pelB signal peptide."
Processing 00000000.tx.12: The Pyr1 substitutional variants maintained similar secondary structures to wild-type onconase, but with less thermostability and specific catalytic activity for the innate substrate UG. 

Phrase: "The Pyr1 substitutional variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "similar secondary structures to wild-type onconase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0175668:Secondary to [Temporal Concept]
           Secondary
   748   C0027627:secondary [Neoplastic Process]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0678594:structures [Spatial Concept]
   745   C0162807:Secondary Structure [Spatial Concept]

Phrase: "but with less thermostability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0597571:thermostability [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "specific catalytic activity for the innate substrate UG."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.13: However, the non-specific catalytic activity for total RNAs varied depending on the relaxation of base specificity. 

Phrase: "However,"

Phrase: "the non-specific catalytic activity for total RNAs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "varied"

Phrase: "depending on the relaxation of base specificity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0002055:base [Inorganic Chemical]
   748   C0035028:Relaxation [Activity]
   748   C0037791:Specificity [Quantitative Concept]
   748   C0178499:Base [Chemical Viewed Functionally]
   748   C1511884:Specificity [Quantitative Concept]
   748   C1880279:Base [Biomedical or Dental Material]
   714   C0725813:depend [Medical Device]
Processing 00000000.tx.14: Pyr1 promoted the structural integrity by forming a hydrogen bond network through Lys9 in 1 and Val96 in 6, and participated in catalytic activity by hydrogen bonds to Lys9 and P1 catalytic phosphate. 

Phrase: "Pyr1"

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the structural integrity by forming"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "a hydrogen bond network through Lys9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1513822:Network [Professional or Occupational Group]
   753   C1705739:Network [Manufactured Object]
   753   C1882071:Network [Conceptual Entity]

Phrase: "in 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "Val96 in 6,"

Phrase: "and"

Phrase: "participated in catalytic activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0243102:catalytic activity [Molecular Function]
   833   C1264638:Catalytic activity [Functional Concept]
   833   C1547012:*Catalytic Activity [Quantitative Concept]
   770   C0007382:Catalytic [Natural Phenomenon or Process]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "by hydrogen bonds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0020276:hydrogen bond [Natural Phenomenon or Process]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "to Lys9"

Phrase: "and"

Phrase: "P1 catalytic phosphate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.15: Residues Thr35 and Asp67 determined B1 base specificity, and Glu91 determined B2 base specificity. 

Phrase: "Residues Thr35"

Phrase: "and"

Phrase: "Asp67"

Phrase: "determined"

Phrase: "B1 base specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "Glu91"

Phrase: "determined"

Phrase: "B2 base specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.16: The cytotoxicity of onconase is largely determined by structural integrity and specific catalytic activity for UG through Pyr1, rather than non-specific activity for total RNAs.  

Phrase: "The cytotoxicity of onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "largely"

Phrase: "determined by structural integrity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205266:integrity [Qualitative Concept]
   770   C0678594:Structural [Spatial Concept]
   770   C0872403:integrity [Individual Behavior]
   770   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "specific catalytic activity for UG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0243102:catalytic activity [Molecular Function]
   806   C1264638:Catalytic activity [Functional Concept]
   806   C1547012:*Catalytic Activity [Quantitative Concept]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "through Pyr1,"

Phrase: "rather than"

Phrase: "non-specific activity for total RNAs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.17: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Ribonucleases are ubiquitous in nature and have been implicated in cellular RNA metabolism and the regulation of gene expression (1,2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ribonucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "ubiquitous in nature"

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in cellular RNA metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0683143:RNA metabolism [Genetic Function]
   797   C1524026:cellular metabolism [Cell Function]
   760   C0007634:Cellular [Cell]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0178539:Cellular [Functional Concept]

Phrase: "and"

Phrase: "the regulation of gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   926   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.18: However, several proteins in the ribonuclease family have other biological functions in addition to the ribonucleolytic activity. 

Phrase: "However,"

Phrase: "several proteins in the ribonuclease family"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   809   C0035542:Ribonuclease Family Protein [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "other biological functions in addition to the ribonucleolytic activity."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   742   C0005532:Biological [Biomedical Occupation or Discipline]
   742   C0205460:biological [Qualitative Concept]
   742   C0542341:Functions [Functional Concept]
   731   C0031845:Biological function, NOS [Physiologic Function]
   708 E C0031843:function [Physiologic Function]
   708 E C0700205:FUNCTION [Classification]
   708 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.19: For example, human RNase 5 (angiogenin) induces blood vessel formation (3); 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "human RNase 5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0051844:RNase-5 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0086418:Human [Human]

Phrase: "(angiogenin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051844:angiogenin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367482:ANGIOGENIN [Gene or Genome]

Phrase: ")"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "blood vessel formation"
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   901   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   901   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   901   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   845 E C1558950:VASCULAR [Finding]
   845 E C1801960:Vascular [Qualitative Concept]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   817 E C0005767:Blood [Tissue]
   817 E C0005768:blood [Body Substance]
   817 E C0229664:Blood [Body Substance]
   817 E C0392895:Bloods [Population Group]
   795 E C0333275:Bloody [Qualitative Concept]
   771 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.20: human RNase 2 [human eosinophil-derived neurotoxin (EDN)] and RNase 3 [human eosinophil cationic protein (ECP)] possess neurotoxicity and antiviral activity (4,5) and bovine seminal ribonuclease exhibits both antitumor and immunosuppressive properties (6). 

Phrase: "human RNase 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0525614:RNase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0086418:Human [Human]

Phrase: "[human eosinophil-derived neurotoxin (EDN)"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   923   C0059409:Eosinophil-Derived Neurotoxin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   923   C1419408:EOSINOPHIL-DERIVED NEUROTOXIN [Gene or Genome]
   812   C0014467:eosinophil [Cell]
   812   C0027934:Neurotoxin [Hazardous or Poisonous Substance]
   812   C0086418:Human [Human]
   812   C1441547:Derived [Qualitative Concept]
   812   C3245521:derived [Idea or Concept]
   741 E C0333930:Eosinophilic [Functional Concept]
   712 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   712 E C1306759:Eosinophilia [Disease or Syndrome]
   712 E C1636667:Eosinophilia [Disease or Syndrome]
   712 E C2240374:Eosinophilia [Finding]

Phrase: "]"

Phrase: "and"

Phrase: "RNase 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0950373:RNase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[human eosinophil cationic protein (ECP)"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C1312650:eosinophil cationic protein, human [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0950373:Eosinophil cationic protein [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1419409:EOSINOPHIL CATIONIC PROTEIN [Gene or Genome]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014467:eosinophil [Cell]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0007447:Cation [Chemical Viewed Structurally]
   741 E C0333930:Eosinophilic [Functional Concept]
   712 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   712 E C1306759:Eosinophilia [Disease or Syndrome]
   712 E C1636667:Eosinophilia [Disease or Syndrome]
   712 E C2240374:Eosinophilia [Finding]

Phrase: "]"

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "antiviral activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0003451:Antiviral [Pharmacologic Substance]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "bovine seminal ribonuclease exhibits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0015272:Exhibits [Intellectual Product]
   756   C0106964:bovine seminal ribonuclease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "both antitumor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986475:Antitumor [Qualitative Concept]

Phrase: "and"

Phrase: "immunosuppressive properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.21: In addition, a group of frog ribonucleases from Rana pipiens, Rana japonica and Rana catesbeiana exert cytotoxic activity towards tumor cells. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a group of frog ribonucleases"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0441835:a group [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "from Rana pipiens,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034653:Rana pipiens [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: "Rana japonica"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0999030:Rana japonica [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1029887:Japonica [Eukaryote]
   861   C1095816:Rana [Amphibian]

Phrase: "and"

Phrase: "Rana catesbeiana"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034651:Rana catesbeiana [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "cytotoxic activity towards tumor cells."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   781   C0022686:Cytotoxic cell [Cell]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   760   C1511636:cytotoxic [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.22: These frog ribonucleases possess distinct characteristics which are not found in most mammalian ribonucleases: they have pyroglutamate (Pyr) at the N-terminus, prefer pyrimidineguanine substrates, demonstrate high thermostability and are not neutralized by the ribonuclease inhibitor from human placenta (712). 

Phrase: "These frog ribonucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "distinct characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found in most mammalian ribonucleases"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0024660:Mammalian [Mammal]
   760   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: ":"

Phrase: "they"

Phrase: "have"

Phrase: "pyroglutamate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Pyr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "at the N-terminus,"

Phrase: "prefer"

Phrase: "pyrimidineguanine substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "demonstrate"

Phrase: "high thermostability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597571:thermostability [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "neutralized by the ribonuclease inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C3539761:Ribonuclease Inhibitor [Amino Acid, Peptide, or Protein]
   760   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "from human placenta"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0032043:Placenta [Embryonic Structure]
   861   C1278988:Placenta [Embryonic Structure]
   861   C1550656:Placenta [Body Substance]
   789 E C0230956:Placental [Mammal]

Phrase: "(712"

Phrase: ")."
Processing 00000000.tx.23: One of frog ribonucleases, onconase from R.pipiens, is currently being evaluated in combination with tamoxifen or doxorubicin in human phase III clinical trials for tumor therapy (7). 

Phrase: "One of frog ribonucleases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "onconase from R.pipiens,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "being"

Phrase: "evaluated in combination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205195:Combination [Qualitative Concept]
   790   C0220825:Evaluated [Functional Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with tamoxifen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   944 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "doxorubicin in human phase III clinical trials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013089:Doxorubicin [Antibiotic,Organic Chemical]

Phrase: "for tumor therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.24: To identify residues or domains responsible for the novel properties of frog ribonuclease, we cloned the onconase gene rpr from genomic DNA and mutated possible residues on the basis of amino acid sequences and structures of ribonucleases. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "or"

Phrase: "domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "responsible for the novel properties of frog ribonuclease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the onconase gene rpr from genomic DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705631:RPR [Gene or Genome]

Phrase: "and"

Phrase: "mutated possible residues on the basis of amino acid sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "structures of ribonucleases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.25: We found that the Pyr1 is involved in thermostability and catalytic activity of onconase and that Asp67 and Glu91 residues participated in the B1 and B2 base specificity, respectively. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the Pyr1"

Phrase: "is"

Phrase: "involved in thermostability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0597571:thermostability [Natural Phenomenon or Process]
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "catalytic activity of onconase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0243102:catalytic activity [Molecular Function]
   833   C1264638:Catalytic activity [Functional Concept]
   833   C1547012:*Catalytic Activity [Quantitative Concept]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "that Asp67"

Phrase: "and"

Phrase: "Glu91 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "participated in the B1"

Phrase: "and"

Phrase: "B2 base specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "respectively."
Processing 00000000.tx.26: Our results demonstrate that the cytotoxicity of onconase is primarily determined by structural integrity and specific catalytic activity for the innate substrate uridineguanine (UG), but not by non-specific catalytic activity for total RNAs.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the cytotoxicity of onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "primarily"

Phrase: "determined by structural integrity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205266:integrity [Qualitative Concept]
   770   C0678594:Structural [Spatial Concept]
   770   C0872403:integrity [Individual Behavior]
   770   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "specific catalytic activity for the innate substrate uridineguanine"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(UG"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not by non-specific catalytic activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0205370:Non-specific [Qualitative Concept]
   790   C0243102:catalytic activity [Molecular Function]
   790   C1264638:Catalytic activity [Functional Concept]
   790   C1547012:*Catalytic Activity [Quantitative Concept]
   753   C0007382:Catalytic [Natural Phenomenon or Process]
   753   C0205177:Activity [Functional Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1518422:Non [Functional Concept]
           Not
   753   C1552740:specific [Intellectual Product]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "for total RNAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.27: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Cloning of onconase gene from genomic DNA Genomic DNA was extracted from the liver of R.pipiens (Nasco Biologicals Co., Fort Atkinson, WI) by DNA zol reagents (Molecular Research Center Inc., Cincinnati, OH) according to the manufacturers instructions. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Cloning of onconase gene"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   819   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0009015:Cloning [Research Activity]
   770   C0017337:Gene [Gene or Genome]
   770   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   737 E C0009013:Clone [Cell]
   737 E C1522642:Clone [Tissue]

Phrase: "from genomic DNA Genomic DNA"

Phrase: "was"

Phrase: "extracted from the liver of R.pipiens"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0034653:R pipiens [Amphibian]
   757   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   748   C0023884:Liver [Body Part, Organ, or Organ Component]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C0205090:R- [Spatial Concept]
   748   C0684010:R. [Professional or Occupational Group]
   748   C0736268:LIVER [Body Part, Organ, or Organ Component]
   748   C1278929:Liver [Body Part, Organ, or Organ Component]
   748   C2346688:LIVER [Food]
   748   C2603358:R' [Clinical Attribute]
   748   C3541890:EXTRACTED [Finding]
   714 E C2828366:Extract [Substance]

Phrase: "(Nasco Biologicals Co.,"

Phrase: "Fort Atkinson,"

Phrase: "WI) by DNA zol reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043193:WI [Geographic Area]

Phrase: "(Molecular Research Center Inc.,"

Phrase: "Cincinnati,"

Phrase: "OH) according to the manufacturers instructions."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0220853:OH- [Element, Ion, or Isotope]
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C1442085:Instructions [Idea or Concept]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
   719   C0947322:Manufacturer [Intellectual Product]
   719   C1705426:Manufacturer [Population Group]
Processing 00000000.tx.28: The onconase gene rpr was amplified by PCR using oligonucleotide primers rap-1 (5'-ATAAAGGCCTGATCACGACTTCCAG-3', nucleotides 7195 of 5' UTR of rap LR1, AF165133 [GenBank] ) and -rap-2 (5'-GCTGCTTATCACATCCCTGTTGTC-3', nucleotides 514491 of 3' UTR of rapLR1, AF165133 [GenBank] ) as 5' and 3' primer, respectively (13,14). 

Phrase: "The onconase gene rpr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705631:RPR [Gene or Genome]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligonucleotide primers rap-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1416920:RAP [Gene or Genome]

Phrase: "(5'-ATAAAGGCCTGATCACGACTTCCAG-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "nucleotides 7195 of 5' UTR of rap LR1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0450766:LR1 [Body Location or Region]
   744   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1416920:RAP [Gene or Genome]
   744   C1420099:UTR [Gene or Genome]
   744   C1540171:UTR [Gene or Genome]

Phrase: "AF165133"

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: "and -"

Phrase: "rap-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416920:RAP [Gene or Genome]

Phrase: "(5'-GCTGCTTATCACATCCCTGTTGTC-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "nucleotides 514491 of 3' UTR of rapLR1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1420099:UTR [Gene or Genome]
   748   C1540171:UTR [Gene or Genome]

Phrase: "AF165133"

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: "as 5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3' primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "respectively"

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.29: Construction of expression vector The amplified onconase gene containing an NdeI (CATATG) and a BamHI (GGATCC) recognition sequence at its 5' and 3' ends, respectively, was inserted into pET22b through the NdeI and BamHI sites (Novagen). 

Phrase: "Construction of expression vector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "The amplified onconase gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an NdeI"

Phrase: "(CATATG"

Phrase: ")"

Phrase: "and"

Phrase: "a BamHI"

Phrase: "(GGATCC"

Phrase: ")"

Phrase: "recognition sequence at its 5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "3' ends,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "respectively,"

Phrase: "was"

Phrase: "inserted into pET22b"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0441587:Inserted [Health Care Activity]
   756 E C1743766:Insert [Medical Device]
   756 E C1883719:Insert [Functional Concept]

Phrase: "through the NdeI"

Phrase: "and"

Phrase: "BamHI sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "(Novagen"

Phrase: ")."
Processing 00000000.tx.30: Therefore, a Met is added to the N-terminus of onconase for translation initiation in Escherichia coli. 

Phrase: "Therefore,"

Phrase: "a Met"

Phrase: "is"

Phrase: "added to the N-terminus of onconase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1524062:Added [Functional Concept]
   714 E C1883712:Add [Functional Concept]

Phrase: "for translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519613:Translation Initiation [Genetic Function]
   861   C0589507:Initiation [Mental Process]
   861   C1158830:Initiation [Genetic Function]
   861   C1704686:Initiation [Functional Concept]

Phrase: "in Escherichia coli."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014834:Escherichia coli [Bacterium]
   861   C0014833:Escherichia [Bacterium]
Processing 00000000.tx.31: Alternatively, the onconase gene is preceded by a NcoI-containing sequence CCATGGCT, which encodes for MetAla, and fused with a modified pelB signal peptide sequence through an NcoI site at its 3' end, before inserting into pET11d through NdeI and BamHI sites (13). 

Phrase: "Alternatively,"

Phrase: "the onconase gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "preceded by a NcoI-containing sequence CCATGGCT,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0332152:preceded [Temporal Concept]
   748   C0332256:Containing [Functional Concept]
   748   C1519249:Sequence [Functional Concept]
   748   C2700400:Containing [Activity]

Phrase: "which"

Phrase: "encodes for MetAla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2700640:Encode [Activity]

Phrase: "and"

Phrase: "fused with a modified pelB signal peptide sequence"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   789   C0037081:Signal Sequence, Peptide [Amino Acid Sequence]
           Signal Peptide
           Signal Sequence
   770   C0920679:peptide sequence [Amino Acid Sequence]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0392747:Modified [Functional Concept]
   744   C0699952:Fused [Functional Concept]
   744   C1519249:Sequence [Functional Concept]
   744   C1710082:Signal [Phenomenon or Process]
   711 E C1414861:FUSE [Gene or Genome]
   711 E C1708111:Fuse [Manufactured Object]

Phrase: "through an NcoI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "at its 3' end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "before"

Phrase: "inserting into pET11d"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0441587:Insert [Health Care Activity]
   756   C1743766:Insert [Medical Device]
   756   C1883719:Insert [Functional Concept]

Phrase: "through NdeI"

Phrase: "and"

Phrase: "BamHI sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.32: The signal sequence is presumably removed in vivo before Gln-ended mature onconase is secreted into the culture medium. 

Phrase: "The signal sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0037081:Signal Sequence [Amino Acid Sequence]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   861   C1710082:Signal [Phenomenon or Process]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "presumably"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "in vivo before Gln-ended mature onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "is"

Phrase: "secreted into the culture medium."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1327616:Secreted [Cell Function]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
Processing 00000000.tx.33: Mutations were made by site-directed mutagenesis. 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "made by site-directed mutagenesis."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   760   C0079866:Mutagenesis [Molecular Function]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   760   C3146302:Mutagenesis [Laboratory Procedure]
   726   C0439851:Direct [Qualitative Concept]
   726   C1881534:Make [Functional Concept]
   726   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.34: Expression and purification of recombinant ribonucleases The recombinant onconase in pET22b or pET11d was expressed in E.coli BL21(DE3) overnight at 37C. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "purification of recombinant ribonucleases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "The recombinant onconase in pET22b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "or"

Phrase: "pET11d"

Phrase: "was"

Phrase: "expressed in E.coli BL21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014834:E coli [Bacterium]
   760   C0450615:BL21 [Body Location or Region]

Phrase: "(DE3"

Phrase: ")"

Phrase: "overnight at 37C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.35: Inclusion bodies were collected, denatured in 6 M guanidine hydrochloride and then refolded in a mixture of reduced and oxidized glutathione (15). 

Phrase: "Inclusion bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0007637:Inclusion Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1512693:Inclusion [Qualitative Concept]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "denatured in 6 M guanidine hydrochloride"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   753   C0018320:guanidine [Organic Chemical]
   753   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "refolded in a mixture of reduced"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Reduced [Qualitative Concept]
   753   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "oxidized glutathione"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061516:Glutathione, Oxidized [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.36: The refolded proteins were purified to electrophoretic homogeneity by carboxymethyl cellulose (CM52, Whatman) column chromatography. 

Phrase: "The refolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "purified to electrophoretic homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1881065:Homogeneity [Qualitative Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "by carboxymethyl cellulose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007068:Carboxymethyl Cellulose [Carbohydrate,Pharmacologic Substance]
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "(CM52,"

Phrase: "Whatman"

Phrase: ")"

Phrase: "column chromatography."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0684296:Column Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
   761 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.37: The soluble onconase secreted into the culture media was concentrated by polyethylene glycol and purified to electrophoretic homogeneity by phosphocellulose (P-11, Whatman) and carboxymethyl cellulose (CM52, Whatman) column chromatography (13). 

Phrase: "The soluble onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "secreted into the culture media"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0162867:Media [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1254021:Media [Tissue]
   760   C1327616:Secreted [Cell Function]
   760   C2242979:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "concentrated by polyethylene glycol"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0017945:Glycol [Organic Chemical]
   770   C0017951:Glycol [Organic Chemical]
   770   C0032487:polyethylene [Biomedical or Dental Material,Organic Chemical]
   770   C0137914:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   770   C0752345:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "purified to electrophoretic homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1881065:Homogeneity [Qualitative Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "by phosphocellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070824:phosphocellulose [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(P-11,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069877:P 11 [Organic Chemical,Pharmacologic Substance]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Whatman"

Phrase: ")"

Phrase: "and"

Phrase: "carboxymethyl cellulose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007068:Carboxymethyl Cellulose [Carbohydrate,Pharmacologic Substance]
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "(CM52,"

Phrase: "Whatman"

Phrase: ")"

Phrase: "column chromatography"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0684296:Column Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.38: The native onconase was purified from the oocytes of R.pipiens as for RC-RNase (9). 

Phrase: "The native onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "was"

Phrase: "purified from the oocytes of R.pipiens"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0034653:R pipiens [Amphibian]
   748   C0029045:Oocytes [Cell]
   748   C0205090:R- [Spatial Concept]
   748   C0684010:R. [Professional or Occupational Group]
   748   C1998793:Purified [Functional Concept]
   748   C2603358:R' [Clinical Attribute]

Phrase: "as for RC-RNase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.39: Analysis of recombinant onconase and its mutants Proteins were separated by 13.3% SDSPAGE and stained by Coomassie brilliant blue R (16). 

Phrase: "Analysis of recombinant onconase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "its mutants Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by 13.3% SDSPAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "stained by Coomassie brilliant blue R (16"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   853   C0056271:Coomassie brilliant blue R [Organic Chemical]
   814   C0056270:coomassie Brilliant Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C0054051:brilliant blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   774   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   748   C0205090:R- [Spatial Concept]
   748   C0684010:R. [Professional or Occupational Group]
   748   C1260957:Blue [Qualitative Concept]
   748   C2603358:R' [Clinical Attribute]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")."
Processing 00000000.tx.40: For western blotting analysis, the immobilized proteins were probed with antibodies raised against onconase isolated from culture medium (17). 

Phrase: "For western blotting analysis,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   988   C0949466:Western blot analysis [Laboratory Procedure]
       E   Western Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "the immobilized proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2350558:Immobilized Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "probed with antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "raised against onconase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0442818:Raised [Quantitative Concept]
   790   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "isolated from culture medium"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Medium [Intellectual Product]
   770   C0010453:Culture [Idea or Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0439536:Medium [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1705217:Medium [Substance]
   770   C2242979:Culture [Laboratory Procedure]
   770   C3244283:medium [Intellectual Product]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.41: The production of antibodies from rabbits was prepared by intra-spleen immunization (18). 

Phrase: "The production of antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0003261:antibodies production [Biologic Function]
   770   C0033268:production [Occupational Activity]

Phrase: "from rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "was"

Phrase: "prepared by intra-spleen immunization"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   760   C0037993:Spleen [Body Part, Organ, or Organ Component]
   760   C0042196:immunisation [Therapeutic or Preventive Procedure]
   760   C0347985:Intra [Temporal Concept]
   760   C0771377:SPLEEN [Tissue]
   760   C1278932:Spleen [Body Part, Organ, or Organ Component]
   760   C3244291:immunization [Functional Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.42: Onconase proteins with N-terminal block were incubated with pfu Pyr aminopeptidase (TaKaRa Biomedicals, Japan) at 70C for 4 h before sequence analysis (13). 

Phrase: "Onconase proteins with N-terminal block"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated with pfu Pyr aminopeptidase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0034307:Pyroglutamate Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0002570:Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1882406:PFU [Quantitative Concept]

Phrase: "(TaKaRa Biomedicals,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "at 70C"

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.43: Alternatively, proteins from inclusion bodies were separated by 13.3% SDSPAGE and contact-transferred to PVDF membrane (Problot, Applied Biosystems) before sequence analysis (13). 

Phrase: "Alternatively,"

Phrase: "proteins from inclusion bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C1325683:protein body [Cell Component]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by 13.3% SDSPAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "contact-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332158:contact [Functional Concept]
  1000   C0337611:Contact [Population Group]
  1000   C1705415:Contact [Idea or Concept]

Phrase: "transferred to PVDF membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025255:Membrane [Tissue]
   770   C0071710:PVDF [Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "(Problot,"

Phrase: "Applied Biosystems"

Phrase: ")"

Phrase: "before"

Phrase: "sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.44: Automatic Edman degradation was performed on a Gas/Liquid phase Model 477A sequencer (Applied Biosystems) equipped with an on-line Model 492 phenyl thiohydantoin-amino acid analyzer (13). 

Phrase: "Automatic Edman degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "performed on a Gas/Liquid phase Model 477A sequencer"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   742   C0017110:Gas [Chemical Viewed Structurally]
   742   C0205390:Phase [Temporal Concept]
   742   C0302908:Liquid [Substance]
   742   C0596601:Gas [Sign or Symptom]
   742   C0884358:Performed [Functional Concept]
   742   C1304698:Liquid [Finding]
   742   C1546699:Liquid NOS [Intellectual Product]
   742   C1561501:Liquid NOS [Substance]
   742   C3161035:Model [Intellectual Product]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Applied Biosystems"

Phrase: ")"

Phrase: "equipped with an on-line Model 492 phenyl thiohydantoin-amino acid analyzer"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0179025:aminoacid analyzer [Medical Device]
   753   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0031504:Phenylthiohydantoin [Organic Chemical]
   753   C2917660:Amino Acid [Pharmacologic Substance]
   736   C0001128:Acid [Chemical]
   736   C0039903:thiohydantoin [Organic Chemical]
   736   C0179038:Analyzer [Medical Device]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0205132:Line [Spatial Concept]
   736   C1550648:Line [Substance]
   736   C1552960:Line [Quantitative Concept]
   736   C1706246:Analyzer [Manufactured Object]
   736   C2945751:phenyl [Chemical Viewed Structurally]
   736   C3161035:Model [Intellectual Product]
   715   C0070570:Phenylic acid [Organic Chemical,Pharmacologic Substance]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.45: Circular dichroism and mass spectrophotometric analysis Circular dichroism (CD) experiments were carried out using an Aviv CD 202 spectrophotometer (Aviv, Lakewood, NJ) calibrated with (+)-10-camphorsulfonic acid at 25C. 

Phrase: "Circular dichroism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: "and"

Phrase: "mass spectrophotometric analysis Circular dichroism (CD) experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0681814:Experiments [Research Activity]
   766 E C1706386:Experiment [Conceptual Entity]
   716 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Aviv CD 202 spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0183400:Spectrophotometer [Medical Device]

Phrase: "(Aviv,"

Phrase: "Lakewood,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: "calibrated with"

Phrase: "(+"

Phrase: ")-"

Phrase: "10-camphorsulfonic acid at 25C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0044656:10-camphorsulfonic acid [Organic Chemical,Pharmacologic Substance]
   806   C2699544:Camphorsulfonic Acid, (+)- [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.46: In general, a 2 mm path-length cuvette with 1020 M ribonuclease in 20 mM sodium phosphate, pH 7.0, was used for CD experiments, and all protein solutions were made up to 1 ml. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "a 2 mm path-length cuvette with 1020 M ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0180266:cuvette [Medical Device]

Phrase: "in 20 mM sodium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "used for CD experiments,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0008813:Circular Dichroism [Laboratory Procedure]
   760   C0596436:dichroism [Natural Phenomenon or Process]
   760   C0681814:Experiments [Research Activity]
   760   C1273517:used [Finding]
   760   C1282913:Circular [Spatial Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "all protein solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "made up to 1 ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1881534:Make [Functional Concept]
Processing 00000000.tx.47: The spectra were recorded from 190 to 260 nm. 

Phrase: "The spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded from 190"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0034869:Record [Intellectual Product]

Phrase: "to 260 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.48: After background subtraction and smoothing, all CD signals (millidegree) were converted into mean residue ellipticity (deg cm2 dmol1). 

Phrase: "After background subtraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348589:Subtraction [Phenomenon or Process]

Phrase: "and"

Phrase: "smoothing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205357:smoothing [Qualitative Concept]
  1000   C1948044:Smoothing [Research Activity]

Phrase: "all CD signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1710082:Signal [Phenomenon or Process]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "(millidegree"

Phrase: ")"

Phrase: "were"

Phrase: "converted into mean residue ellipticity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0444504:Mean [Quantitative Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "(deg cm2 dmol1"

Phrase: ")."
Processing 00000000.tx.49: Equilibrium thermo-denaturing experiments were performed by measuring changes of molar ellipticity at 200 nm. 

Phrase: "Equilibrium thermo-denaturing experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed by measuring changes of molar ellipticity"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   778   C1550369:Performed By [Qualitative Concept]
   748   C0026367:Molar [Body Part, Organ, or Organ Component]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   748   C0444706:measuring [Qualitative Concept]
   748   C0449770:measuring [Quantitative Concept]
   748   C0884358:Performed [Functional Concept]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C1705241:Change [Quantitative Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at 200 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.50: Data were collected as a function of temperature at a scan rate of 2C/min over the range 2095C in 20 mM sodium phosphate buffer, pH 7.0. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected as a function of temperature"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0005903:temperature [Organism Attribute]
   753   C0031843:function [Physiologic Function]
   753   C0039476:*Temperature [Quantitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   753   C1705273:Function [Intellectual Product]

Phrase: "at a scan rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "of 2C/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "over the range 2095C"

Phrase: "in 20 mM sodium phosphate buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.0."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.51: The variation was monitored at 200 nm after 3 min equilibration at each point with a temperature controller. 

Phrase: "The variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "was"

Phrase: "monitored at 200 nm"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0312860:NM [Cell Function]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "after 3 min equilibration"

Phrase: "at each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "with a temperature controller."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0180112:Controller [Medical Device]
Processing 00000000.tx.52: The mass spectrophotometric (MS) analyses of C4 column-desalted ribonucleases in 0.3% formic acid and 50% acetonitrile (v/v) were performed on a Micromass Q-TOF UltimaTM API spectrophotometer (Micromass, Wythenshawe, UK) equipped with an orthogonal electrospray source operated in the positive ion mode. 

Phrase: "The mass spectrophotometric (MS) analyses of C4 column-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "desalted"

Phrase: "ribonucleases in 0.3% formic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0001113:Acid Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0073240:Ribonuclease 3 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "50% acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]

Phrase: "(v/v)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560268:%V/V [Quantitative Concept]
  1000   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "were"

Phrase: "performed on a Micromass Q-TOF UltimaTM API spectrophotometer"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0039685:TOF [Congenital Abnormality]
   742   C0183400:Spectrophotometer [Medical Device]
   742   C0884358:Performed [Functional Concept]
   742   C1825291:TOF [Gene or Genome]
   742   C2348791:TOF [Quantitative Concept]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Micromass,"

Phrase: "Wythenshawe,"

Phrase: "UK"

Phrase: ")"

Phrase: "equipped with an orthogonal electrospray source"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]

Phrase: "operated in the positive ion mode."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0022023:Ion [Element, Ion, or Isotope]
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1513371:Mode [Functional Concept]
   753   C1514241:Positive [Finding]
   753   C1700702:ION [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]
   753   C2825490:Positive [Qualitative Concept]
   719   C3242339:operate [Functional Concept]
Processing 00000000.tx.53: Ribonuclease activity assay The ribonuclease activity of column eluates was determined by their abilities to cleave dinucleotide UG in 50 mM sodium acetate, pH 6.0, 50 mM sodium chloride and 0.1 g/l bovine serum albumin. 

Phrase: "Ribonuclease activity assay"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1148840:ribonuclease activity [Genetic Function]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0205177:Activity [Functional Concept]
   827   C0243073:assay [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "The ribonuclease activity of column eluates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1148840:ribonuclease activity [Genetic Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by their abilities to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Abilities [Organism Attribute]

Phrase: "cleave"

Phrase: "dinucleotide UG in 50 mM sodium acetate,"

Phrase: "pH 6.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50 mM sodium chloride"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0037494:Sodium Chloride [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0596019:Chloride [Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1 g/l bovine serum albumin."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   818   C0728877:serum albumin [Laboratory or Test Result]
   795   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0007452:Bovine [Mammal]
   795   C0229671:Serum [Body Substance]
   795   C1140701:bovine [Mammal]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]
Processing 00000000.tx.54: The digestion products were separated by thin layer chromatography (PEI-cellulose, F Merck, Darmstadt, Germany) in 0.25 M lithium chloride1.0 M acetic acid, and visualized under UV illumination at 254 nm (16). 

Phrase: "The digestion products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by thin layer chromatography"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0205168:Thin [Qualitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]

Phrase: "(PEI-cellulose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "F Merck,"

Phrase: "Darmstadt,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "in 0.25 M lithium chloride1.0 M acetic acid,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   807   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   807   C0000985:Acetic acid [Organic Chemical]
   791   C0001128:Acid [Chemical]
   791   C0202406:Acid [Laboratory Procedure]
   791   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   735 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "visualized under UV illumination"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023693:Illumination [Natural Phenomenon or Process]
   770   C0023700:Illumination [Human-caused Phenomenon or Process]
   770   C0041625:UV [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C0684292:illumination [Laboratory Procedure]
   770   C1961129:uV [Quantitative Concept]
   770   C1964256:Illumination [Diagnostic Procedure]

Phrase: "at 254 nm (16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: ")."
Processing 00000000.tx.55: Ribo nuclease activities were also analyzed by zymogram assay on RNA-casting PAGE (19). 

Phrase: "Ribo nuclease activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1148806:nuclease activity [Genetic Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "also"

Phrase: "analyzed by zymogram assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0936012:Analyzed [Research Activity]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "on RNA-casting PAGE (19"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1704732:Page [Intellectual Product]
   779   C0179686:Cast [Medical Device]
   779   C0302143:Cast [Body Substance]

Phrase: ")."
Processing 00000000.tx.56: Briefly, after electrophoresis the gel was washed twice with 25% isopropyl alcohol in 10 mM TrisHCl, pH 7.5, to remove SDS for protein renaturation. 

Phrase: "Briefly,"

Phrase: "after"

Phrase: "electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "the gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with 25% isopropyl alcohol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0022237:Isopropyl Alcohol [Organic Chemical,Pharmacologic Substance]
   760   C0001962:ALCOHOL [Organic Chemical]
   760   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]
   760   C2945717:isopropyl [Chemical Viewed Structurally]

Phrase: "in 10 mM TrisHCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "SDS for protein renaturation."
Processing 00000000.tx.57: The activity was visible after incubating the gel at room temperature for 30 min in 10 mM TrisHCl, pH 7.5, then in 0.2% Toluidine blue O for 10 min. 

Phrase: "The activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "visible after incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205379:Visible [Qualitative Concept]

Phrase: "the gel at room temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "in 10 mM TrisHCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "then in 0.2% Toluidine blue O"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0040380:Toluidine Blue O [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Toluidine Blue
   774   C0046584:toluidine o [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0002593:Toluidine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1260957:Blue [Qualitative Concept]
   748   C1883708:Then [Temporal Concept]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.58: The non-specific catalytic activity of ribonuclease was determined by the release of acid-soluble ribonucleotides from the RNA substrate after ribonuclease digestion (20). 

Phrase: "The non-specific catalytic activity of ribonuclease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0243102:catalytic activity [Molecular Function]
   778   C1264638:Catalytic activity [Functional Concept]
   778   C1547012:*Catalytic Activity [Quantitative Concept]
   774   C1148840:ribonuclease activity [Genetic Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by the release of acid-soluble ribonucleotides"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0001128:Acid [Chemical]
   744   C0030685:Release [Health Care Activity]
   744   C0035548:Ribonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the RNA substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "after ribonuclease digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.59: Briefly, an excess amount of yeast total RNA (120 g) was incubated with purified onconase or its variant in 50 l of 50 mM sodium acetate, pH 6.0, 50 mM sodium chloride and 0.1 g/l bovine serum albumin, at 37C for 15 min, and the reaction was terminated by the addition of ice-cold stop solution (7% perchloric acid, 0.1% uranyl acetate, 200 l). 

Phrase: "Briefly,"

Phrase: "an excess amount of yeast total RNA (120 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with purified onconase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1998793:Purified [Functional Concept]

Phrase: "or"

Phrase: "its variant in 50 l of 50 mM sodium acetate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205419:Variant [Qualitative Concept]

Phrase: "pH 6.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50 mM sodium chloride"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0037494:Sodium Chloride [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0596019:Chloride [Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1 g/l bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   818   C0728877:serum albumin [Laboratory or Test Result]
   795   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0007452:Bovine [Mammal]
   795   C0229671:Serum [Body Substance]
   795   C1140701:bovine [Mammal]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]

Phrase: "at 37C"

Phrase: "for 15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by the addition of ice-cold stop solution"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0456963:Ice cold [Qualitative Concept]
   742   C0009264:Cold [Natural Phenomenon or Process]
   742   C0009443:Cold [Disease or Syndrome]
   742   C0020746:Ice [Inorganic Chemical]
   742   C0037633:Solution [Substance]
   742   C0234192:Cold [Physiologic Function]
   742   C0525069:Solution [Biomedical or Dental Material]
   742   C1553404:terminated [Idea or Concept]
   742   C1883712:Addition [Functional Concept]
   742   C1947925:Stop [Activity]
   742   C2348570:Terminated [Functional Concept]
   742   C2746065:Stop [Temporal Concept]

Phrase: "(7% perchloric acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0030981:Perchloric acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "0.1% uranyl acetate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "200 l)."
Processing 00000000.tx.60: The reaction mixtures remained on ice for 30 min before centrifugation (12 000 g, 4C for 20 min). 

Phrase: "The reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "remained on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020746:Ice [Inorganic Chemical]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "before centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "(12 000 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "4C for 20 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0450376:4c [Intellectual Product]
Processing 00000000.tx.61: There was a linear relationship between enzyme activity and optical density at supernatent absorbance (at 260 nm) values between 0.1 and 0.3. 

Phrase: "There"

Phrase: "was"

Phrase: "a linear relationship between enzyme activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "optical density at supernatent absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0439164:Optical density [Quantitative Concept]
   806   C1268822:Optical density [Clinical Attribute]
   760   C0178587:density [Quantitative Concept]
   704   C0042789:Vision [Organism Function]
   704   C2707266:Vision [Clinical Attribute]

Phrase: "("

Phrase: "at 260 nm) values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "between 0.1"

Phrase: "and"

Phrase: "0.3."
Processing 00000000.tx.62: One unit of ribonuclease activity is defined as the amount of enzyme producing one A260 acid-soluble material at 37C for 15 min. 

Phrase: "One unit of ribonuclease activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439148:Unit [Quantitative Concept]
   760   C1519795:Unit [Quantitative Concept]
   760   C1704753:Unit [Manufactured Object]
   760   C1880519:Unit [Quantitative Concept]

Phrase: "is"

Phrase: "defined as the amount of enzyme producing one A260 acid-soluble material"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   736   C0001128:Acid [Chemical]
   736   C0014442:Enzyme [Enzyme,Organic Chemical]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0205447:One [Quantitative Concept]
   736   C0520510:Material [Substance]
   736   C1265611:Amount [Quantitative Concept]
   736   C1704788:Defined [Conceptual Entity]
   736   C1706688:A260 [Molecular Biology Research Technique]
   736   C1749467:soluble [Cell Component]
   736   C1948047:Soluble [Qualitative Concept]
   736   C3539106:Defined [Intellectual Product]

Phrase: "at 37C"

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.63: Base specificity of ribonucleases The specific cleavage sites of onconase on 5' 32P-labeled synthetic 18mer RNA, AAGGUUAUCCGCACUGAA, in 50 mM sodium acetate, pH 6.0, 50 mM sodium chloride and 0.1 g/l bovine serum albumin were determined by denaturing gel electrophoresis and autoradiography (21). 

Phrase: "Base specificity of ribonucleases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "The specific cleavage sites of onconase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   773   C2945843:Site of [Qualitative Concept]
   767   C0449604:Specific site [Spatial Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "on 5' 32P-labeled synthetic 18mer RNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "AAGGUUAUCCGCACUGAA,"

Phrase: "in 50 mM sodium acetate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 6.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50 mM sodium chloride"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0037494:Sodium Chloride [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0596019:Chloride [Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1 g/l bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   818   C0728877:serum albumin [Laboratory or Test Result]
   795   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0007452:Bovine [Mammal]
   795   C0229671:Serum [Body Substance]
   795   C1140701:bovine [Mammal]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "determined by denaturing gel electrophoresis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "autoradiography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.64: The kcat/Km values of ribonuclease towards dinucleotides, e.g. 

Phrase: "The kcat/Km values of ribonuclease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "towards dinucleotides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0012476:dinucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "e.g."
Processing 00000000.tx.65: CG and UG, were measured by HPLC separation and quantification (20,22). 

Phrase: "CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "UG,"

Phrase: "were"

Phrase: "measured by HPLC separation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0008562:HPLC [Laboratory Procedure]
   770   C0036679:Separation [Pathologic Function]
   770   C0237868:Separation [Social Behavior]
   770   C0444706:Measured [Qualitative Concept]
   770   C1881713:SEPARATION [Phenomenon or Process]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "(20,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.66: Briefly, the amount of onconase variant, which digests 1 g of dinucleotide in a 20 l reaction mixture containing 100 mM MES, pH 6.0, 50 mM NaCl and 0.1 g/l bovine serum albumin at 37C in 10 min, was taken for analysis. 

Phrase: "Briefly,"

Phrase: "the amount of onconase variant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "which"

Phrase: "digests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:Digests [Physiologic Function]

Phrase: "1 g of dinucleotide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   770   C0439267:g% [Quantitative Concept]

Phrase: "in a 20 l reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0265215:MES [Congenital Abnormality]
   827   C1417092:MES [Gene or Genome]

Phrase: "pH 6.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.1 g/l bovine serum albumin at 37C"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   764   C0728877:serum albumin [Laboratory or Test Result]
   762 E C0523465:Albumin - serum [Laboratory Procedure]
   742   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007452:Bovine [Mammal]
   742   C0229671:Serum [Body Substance]
   742   C1140701:bovine [Mammal]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]

Phrase: "in 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "taken for analysis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.67: Excess amounts of dinucleotides ranging from 2 to 16 g were used as substrates for the reaction. 

Phrase: "Excess amounts of dinucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "ranging from 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 16 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "used as substrates"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1710236:Substrate [Manufactured Object]
   756 E C1947944:Use [Intellectual Product]

Phrase: "for the reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.68: Digested nucleotides were separated by reverse-phase HPLC using 15% acetonitrile (depending on products) in 0.1% trifluoroacetic acid on a Vydac C18 column with a Waters automated gradient controller. 

Phrase: "Digested nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "separated by reverse-phase HPLC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0205390:Phase [Temporal Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "15% acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]

Phrase: "("

Phrase: "depending on products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1514468:Products [Entity]
   756   C0725813:depend [Medical Device]
   756 E C1704444:Product [Quantitative Concept]

Phrase: ")"

Phrase: "in 0.1% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "on a Vydac C18 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "with a Waters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   966 E C0599638:WATER [Substance]
   966 E C1550678:Water [Inorganic Chemical]
   916 E C0443350:Watery [Qualitative Concept]

Phrase: "automated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205554:Automated [Functional Concept]
   966 E C1072074:Automate [Eukaryote]

Phrase: "gradient controller."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0180112:Controller [Medical Device]
Processing 00000000.tx.69: The amounts of substrate and product (guanosine) were determined using Waters 991 Integrator. 

Phrase: "The amounts of substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "(guanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Waters 991 Integrator."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0309311:INTEGRATOR [Amino Acid, Peptide, or Protein,Pharmacologic Substance,Vitamin]
   827   C1706057:Integrator [Medical Device]
Processing 00000000.tx.70: The kcat/Km values were calculated by LineweaverBurk plot. 

Phrase: "The kcat/Km values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated by LineweaverBurk plot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.71: Values were obtained from the average of at least two independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from the average of"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1301820:Obtained [Functional Concept]
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "at least two independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.72: Assay of cytotoxicity by ATP Lite-M measurement HeLa cells (5 x 103) were cultured in a 96-well plate, each well containing 100 l of Dulbeccos modified Eagles medium with 10% fetal calf serum, and treated with 2 M onconase or variants for 72 h. 

Phrase: "Assay of cytotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0201622:Cytotoxicity assay [Laboratory Procedure]
   790   C0005507:Assay [Laboratory Procedure]
   790   C0243073:assay [Qualitative Concept]
   790   C1510438:Assay [Laboratory Procedure]

Phrase: "by ATP Lite-M measurement HeLa cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   841   C0599757:M-cell [Cell]
   827   C0018873:HeLa Cells [Cell]
           HeLa
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(5 x 103"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "cultured in a 96-well plate,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C0180454:Culture plate [Medical Device]
   753   C0005971:Plate [Medical Device]
   753   C0205170:Well [Qualitative Concept]
   753   C1139930:plate [Medical Device]
   753   C3146287:Well [Manufactured Object]
   753   C3537155:Plate [Manufactured Object]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "each well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 l of Dulbeccos"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "Eagles medium with 10% fetal calf serum,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0009458:Medium [Intellectual Product]
   748   C0439536:Medium [Quantitative Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "treated with 2 M onconase"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "variants for 72 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.73: Fifty microliters of lysis buffer was added to each well and incubated for 2 min before 50 l of substrate solution was added. 

Phrase: "Fifty microliters of lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439243:microliter [Quantitative Concept]

Phrase: "was"

Phrase: "added to each well"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated for 2 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "before 50 l"

Phrase: "of substrate solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.74: The luminescence was measured by a Top Count Microplate Scintillation Counter in a dark adapt plate (Packard A Canberra Company) according to the manufacturers instructions (ATP Lite-M assay system; Packard BioScience Company, the Netherlands) (13).  

Phrase: "The luminescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1450275:luminescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured by a Top Count Microplate Scintillation Counter"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0036405:Scintillation Counter [Medical Device]
   770   C1710025:Scintillation Counter [Manufactured Object]
   744   C0444706:Measured [Qualitative Concept]
   744   C0677601:Counter [Manufactured Object]
   744   C0678573:scintillation [Natural Phenomenon or Process]
   744   C0750480:Count [Activity]
   744   C1704458:Top [Spatial Concept]
   744   C1705206:Counter [Medical Device]
   744   C1705566:Count [Quantitative Concept]
   744   C1709027:Microplate [Research Device]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "in a dark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]

Phrase: "adapt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2937289:adapt [Organic Chemical]

Phrase: "plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(Packard A Canberra Company"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0683757:Company [Manufactured Object,Organization]

Phrase: ")"

Phrase: "according to the manufacturers instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "(ATP Lite-M assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "; Packard BioScience Company,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683757:Company [Manufactured Object,Organization]

Phrase: "the Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.75: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Cloning of onconase gene from genomic DNA The onconase gene rpr was cloned from the genomic DNA of R.pipiens by PCR. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Cloning of onconase gene"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   819   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0009015:Cloning [Research Activity]
   770   C0017337:Gene [Gene or Genome]
   770   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   737 E C0009013:Clone [Cell]
   737 E C1522642:Clone [Tissue]

Phrase: "from genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "The onconase gene rpr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705631:RPR [Gene or Genome]

Phrase: "was"

Phrase: "cloned from the genomic DNA of R.pipiens"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0034653:R pipiens [Amphibian]
   770   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   767   C0012933:r-dna [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0009013:cloned [Cell]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017428:Genomic [Gene or Genome]
   744   C0205090:R- [Spatial Concept]
   744   C0684010:R. [Professional or Occupational Group]
   744   C0887950:genomic [Biomedical Occupation or Discipline]
   744   C2603358:R' [Clinical Attribute]
   711 E C1522642:Clone [Tissue]

Phrase: "by PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]
Processing 00000000.tx.76: Its sequence is deposited in the GenBank database under the accession number AF332139 [GenBank] . The native rpr gene encodes a mature protein of 104 residues preceded by a putative signal peptide of 23 residues which is identical to the signal peptide of rapLR1 from R.pipiens (14). 

Phrase: "Its sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "deposited in the GenBank database"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0242356:Database [Intellectual Product]
   760   C0333562:deposited [Functional Concept]
   760   C0598211:GenBank [Intellectual Product]
   760   C0993637:Data Base [Intellectual Product]

Phrase: "under the accession number AF332139"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "] ."

Phrase: "The native rpr gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a mature protein of 104 residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "preceded by a putative signal peptide of 23 residues"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0037081:Signal Peptide [Amino Acid Sequence]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0332152:preceded [Temporal Concept]
   742   C0450348:23 [Quantitative Concept]
   742   C1710082:Signal [Phenomenon or Process]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "which"

Phrase: "is"

Phrase: "identical to the signal peptide of rapLR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "from R.pipiens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034653:R pipiens [Amphibian]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.77: The deduced amino acid sequence of the rpr gene is identical to the corresponding sequence of native onconase isolated from oocytes, but is different from that of rapLR1 in four amino acid residues: I11L, D20N, K85T and S103H (14). 

Phrase: "The deduced amino acid sequence of the rpr gene"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0202406:Acid [Laboratory Procedure]
   742   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "identical to the corresponding sequence of native onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205280:Identical [Qualitative Concept]

Phrase: "isolated from oocytes,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0029045:Oocytes [Cell]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "but"

Phrase: "is"

Phrase: "different from that of rapLR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "in four amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: ":"

Phrase: "I11L,"

Phrase: "D20N,"

Phrase: "K85T"

Phrase: "and"

Phrase: "S103H"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.78: Expression and purification of onconase The recombinant onconase, rMOnc, collected from inclusion bodies, was denatured, refolded and purified to electrophoretic homogeneity with a yield of 4050 mg per liter of culture (Figs 1 and 2). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "purification of onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243114:purification [Functional Concept]
   790   C1998793:Purification [Functional Concept]

Phrase: "The recombinant onconase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "rMOnc,"

Phrase: "collected from inclusion bodies,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0007637:Inclusion Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1512693:Inclusion [Qualitative Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "was"

Phrase: "denatured"

Phrase: ","

Phrase: "refolded"

Phrase: "and"

Phrase: "purified to electrophoretic homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1881065:Homogeneity [Qualitative Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "with a yield"

Phrase: "of 4050 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "per liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475211:liter [Quantitative Concept]

Phrase: "of culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "(Figs 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.79: Similar results were obtained for the Q1A and Q1S mutants, designated as rMOnc-Q1A and rMOnc-Q1S, respectively (Table 1). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for the Q1A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "Q1S mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "designated as rMOnc-Q1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1524084:Designated [Functional Concept]

Phrase: "and"

Phrase: "rMOnc-Q1S,"

Phrase: "respectively"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: When a modified pelB signal peptide was introduced in front of the onconase, the recombinant protein was expressed predominantly in inclusion bodies with trace amounts in the soluble fractions (Fig. 1A and B). 

Phrase: "When"

Phrase: "a modified pelB signal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037081:Signal Peptide [Amino Acid Sequence]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "introduced in front of the onconase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0205094:front [Spatial Concept]
   753   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   719   C1292748:introduce [Functional Concept]

Phrase: "the recombinant protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514798:recombinant [Organism]

Phrase: "was"

Phrase: "expressed"

Phrase: "predominantly in inclusion bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0007637:Inclusion Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1512693:Inclusion [Qualitative Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "with trace amounts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0442822:trace amount [Quantitative Concept]
   861   C1265611:amounts [Quantitative Concept]

Phrase: "in the soluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.81: The proteins, rOnc and rOnc-Q1E, in inclusion bodies, were processed as described above with a yield of 4050 mg per liter of culture (Table 1). 

Phrase: "The proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "rOnc"

Phrase: "and"

Phrase: "rOnc-Q1E,"

Phrase: "in inclusion bodies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0007637:Inclusion Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1512693:Inclusion [Qualitative Concept]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "were"

Phrase: "processed as described above"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1522240:Processed [Phenomenon or Process]
   770   C1552738:described [Idea or Concept]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "with a yield"

Phrase: "of 4050 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "per liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475211:liter [Quantitative Concept]

Phrase: "of culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: In contrast, the ribonucleolytic activity of these secreted variants, sOnc, sOnc-Q1E and sMOnc-Q1S, was detected directly in the culture medium (70%) without refolding and purified to electrophoretic homogeneity with a yield of 25 mg per liter of culture (Figs 1 and 2). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the ribonucleolytic activity of these secreted variants,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "sOnc,"

Phrase: "sOnc-Q1E"

Phrase: "and"

Phrase: "sMOnc-Q1S,"

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "directly in the culture medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C1947931:Directly [Qualitative Concept]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]

Phrase: "(70%"

Phrase: ")"

Phrase: "without refolding"

Phrase: "and"

Phrase: "purified to electrophoretic homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1881065:Homogeneity [Qualitative Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "with a yield"

Phrase: "of 25 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "per liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475211:liter [Quantitative Concept]

Phrase: "of culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "(Figs 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.83: View larger version (65K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(65K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.84: Analysis of onconase expression in E.coli. 

Phrase: "Analysis of onconase expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in E.coli."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014834:E coli [Bacterium]
Processing 00000000.tx.85: Escherichia coli cultures and equivalent amounts of supernatant and pellets of cell lysates were taken for analysis. 

Phrase: "Escherichia coli cultures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]
   734   C0014834:Escherichia coli [Bacterium]

Phrase: "and"

Phrase: "equivalent amounts of supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "pellets of cell lysates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0993610:pellets [Biomedical or Dental Material]
   737 E C0441436:Pellet [Manufactured Object]
   737 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "taken for analysis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.86: (A) SDSPAGE analysis of protein components. 

Phrase: "(A"

Phrase: ")"

Phrase: "SDSPAGE analysis of protein components."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.87: Twenty microliters of onconase and Met-tagged onconase-transformed E.coli culture were taken for 13.3% SDSPAGE and Coomassie blue staining. 

Phrase: "Twenty microliters of onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439243:microliter [Quantitative Concept]

Phrase: "and"

Phrase: "Met-tagged onconase-transformed E.coli culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0010453:Culture [Idea or Concept]
   795   C0220814:culture [Functional Concept]
   795   C0430400:Culture [Laboratory Procedure]
   795   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "taken for 13.3% SDSPAGE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "Coomassie blue staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.88: (B) Western blotting analysis. 

Phrase: "(B) Western blotting analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   912   C0949466:Western blot analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
Processing 00000000.tx.89: Two microliters of the E.coli culture was taken for 13.3% SDSPAGE and probed with antibodies raised against sOnc. 

Phrase: "Two microliters of the E.coli culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439243:microliter [Quantitative Concept]

Phrase: "was"

Phrase: "taken for 13.3% SDSPAGE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "probed with antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "raised against sOnc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442818:Raised [Quantitative Concept]
Processing 00000000.tx.90: (C) Zymogram analysis. 

Phrase: "(C"

Phrase: ")"

Phrase: "Zymogram analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.91: Two microliters of E.coli culture was taken for RNA-casting 13.3% SDSPAGE and stained by Toluidine blue O. 

Phrase: "Two microliters of E.coli culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439243:microliter [Quantitative Concept]

Phrase: "was"

Phrase: "taken for RNA-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "casting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179686:Cast [Medical Device]
   966   C0302143:Cast [Body Substance]

Phrase: "13.3% SDSPAGE"

Phrase: "and"

Phrase: "stained by Toluidine blue O."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   883   C0523203:Toluidine blue O stain [Laboratory Procedure]
   862   C0040380:Toluidine Blue O [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Toluidine blue stain
           Toluidine Blue
   797   C0046584:toluidine o [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0002593:Toluidine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1260957:Blue [Qualitative Concept]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.92: C, purified onconase as a control [2 g in (A), 0.1 g in (B), 0.5 g in (C)]; 

Phrase: "C,"

Phrase: "purified onconase as a control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "[2 g in (A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "0.1 g in (B"

Phrase: ")"

Phrase: ","

Phrase: "0.5 g in (C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "]"

Phrase: ";"
Processing 00000000.tx.93: S and P, the supernatant and pellets of cell lysate, respectively; 

Phrase: "S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellets of cell lysate,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0993610:pellets [Biomedical or Dental Material]
   737 E C0441436:Pellet [Manufactured Object]
   737 E C1998480:Pellet [Quantitative Concept]

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.94: M, the E.coli culture medium.  

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "the E.coli culture medium."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Medium [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C2242979:Culture [Laboratory Procedure]
   812   C3244283:medium [Intellectual Product]
Processing 00000000.tx.95: View larger version (57K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.96: Analysis of onconase variants. 

Phrase: "Analysis of onconase variants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.97: (A) SDSPAGE. 

Phrase: "(A"

Phrase: ")"

Phrase: "SDSPAGE."
Processing 00000000.tx.98: Two micrograms of purified onconase variants were taken for 13.3% SDSPAGE and Coomassie blue staining. 

Phrase: "Two micrograms of purified onconase variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "taken for 13.3% SDSPAGE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "Coomassie blue staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.99: (B) Western blotting. 

Phrase: "(B) Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.100: (C) Zymogram. 

Phrase: "(C"

Phrase: ")"

Phrase: "Zymogram."
Processing 00000000.tx.101: Onconase variants (0.2 g) were employed for (B) and (C). 

Phrase: "Onconase variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "(0.2 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "employed for"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0557351:Employed [Finding]
   799 E C0457083:Employ [Functional Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and ("

Phrase: "C"

Phrase: ")."
Processing 00000000.tx.102: The abbreviation of each variant is explained in the text.  

Phrase: "The abbreviation of each variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0000723:Abbreviation [Intellectual Product]

Phrase: "is"

Phrase: "explained in the text."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.103: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.104: Nomenclature of onconase and N-terminal variants expressed in E.coli BL21(DE3)  Characterization of recombinant onconases Determination of N-terminal residue. 

Phrase: "Nomenclature of onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600281:Nomenclature [Intellectual Product]
   790   C1524067:Nomenclature [Intellectual Product]

Phrase: "and"

Phrase: "N-terminal variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "expressed in E.coli BL21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014834:E coli [Bacterium]
   760   C0450615:BL21 [Body Location or Region]

Phrase: "(DE3"

Phrase: ")"

Phrase: "Characterization of recombinant onconases Determination of N-terminal residue."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]
Processing 00000000.tx.105: The N-terminal residue of rMOnc from inclusion bodies was Met, while that of rMOnc-Q1A and rMOnc-Q1S was Ala and Ser, respectively. 

Phrase: "The N-terminal residue of rMOnc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "from inclusion bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0007637:Inclusion Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1512693:Inclusion [Qualitative Concept]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "was"

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: ","

Phrase: "while"

Phrase: "that of rMOnc-Q1A"

Phrase: "and"

Phrase: "rMOnc-Q1S"

Phrase: "was"

Phrase: "Ala"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   907 E C0043189:Wing [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Ser,"

Phrase: "respectively."
Processing 00000000.tx.106: The Met preceding Ala or Ser may be removed by the E.coli methionine aminopeptidase, which is unable to remove the initiator Met preceding the bulkier residue, i.e. 

Phrase: "The Met preceding Ala"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   755   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   734 E C0043189:Wing [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "Ser"

Phrase: "may"

Phrase: "be"

Phrase: "removed by the E.coli methionine aminopeptidase,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0014834:E coli [Bacterium]
   778   C0127863:Methionine aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0002570:Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0849355:Removed [Qualitative Concept]
   714 E C1883720:Remove [Activity]
   714 E C3244314:remove [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the initiator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Initiator [Qualitative Concept]

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "the bulkier residue,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.107: Gln. 

Phrase: "Gln."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.108: However, the Met preceding the Ser of onconase secreted into the culture medium through the pelB signal peptide was not removed, as detected by Edman degradation and MS analyses (Fig. 3). 

Phrase: "However,"

Phrase: "the Met preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332152:Preceding [Temporal Concept]

Phrase: "the Ser of onconase"

Phrase: "secreted into the culture medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1327616:Secreted [Cell Function]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]

Phrase: "through the pelB signal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037081:Signal Peptide [Amino Acid Sequence]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "detected by Edman degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243125:degradation [Functional Concept]
   770   C0442726:Detected [Finding]
   770   C0699900:Degradation [Organism Function]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "MS analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.109: The N-termini of pelB-derived rOnc and rOnc-Q1E in inclusion bodies were Gln and Glu, respectively, as detected by Edman degradation. 

Phrase: "The N-termini of pelB-derived rOnc"

Phrase: "and"

Phrase: "rOnc-Q1E in inclusion bodies"

Phrase: "were"

Phrase: "Gln"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Glu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively,"

Phrase: "as"

Phrase: "detected by Edman degradation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243125:degradation [Functional Concept]
   770   C0442726:Detected [Finding]
   770   C0699900:Degradation [Organism Function]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.110: However, the N-terminus of the above-mentioned rOnc was a mixture of Gln and Pyr because two forms were identified from MS analysis: one (11 819 Da) represents matured Pyr-initiated onconase and the other (11836 Da) represents its precursor with Gln at the N-terminus (Fig. 3). 

Phrase: "However,"

Phrase: "the N-terminus of the above-mentioned rOnc"

Phrase: "was"

Phrase: "a mixture of Gln"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "Pyr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "because"

Phrase: "two forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "identified from MS analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0577559:Mass [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1524024:analysis [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C3152252:Mass [Quantitative Concept]

Phrase: ":"

Phrase: "one (11 819 Da)"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "matured Pyr-initiated onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "the other"

Phrase: "(11836 Da)"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "its precursor with Gln"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709634:Precursor [Idea or Concept]

Phrase: "at the N-terminus"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.111: The conversion of N-terminal Gln to Pyr was complete within 2 weeks at 4C in 20 mM sodium phosphate, pH 7.0 (Fig. 3). 

Phrase: "The conversion of N-terminal Gln to Pyr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439836:Conversion [Functional Concept]

Phrase: "was"

Phrase: "complete within 2 weeks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205197:Complete [Qualitative Concept]
   770   C0725685:COMPLEAT [Food]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "in 20 mM sodium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.112: The N-terminus of sOnc secreted the into culture medium was presumably Pyr, identical to native onconase, because no signal was obtained by Edman degradation and only one form (11 819 Da) was observed from MS analysis (Fig. 3). 

Phrase: "The N-terminus of sOnc"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "the into culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Medium [Intellectual Product]
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C2242979:Culture [Laboratory Procedure]
   770   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "presumably Pyr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "identical to native onconase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205280:Identical [Qualitative Concept]

Phrase: "because"

Phrase: "no signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "obtained by Edman degradation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "only one form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "(11 819 Da)"

Phrase: "was"

Phrase: "observed from MS analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1524024:analysis [Functional Concept]
   760   C3152252:Mass [Quantitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.113: After pfu Pyr aminopeptidase treatment, however, the first five residues (AspTrpAlaLeuThr) are identical to those deduced from the DNA sequence. 

Phrase: "After pfu Pyr aminopeptidase treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "however,"

Phrase: "the first five residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(AspTrpAlaLeuThr"

Phrase: ")"

Phrase: "are"

Phrase: "identical to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "deduced from the DNA sequence."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.114: The N-terminal residue of pelB-derived rOnc-Q1E from inclusion bodies was Glu only (Table 1), but that of sOnc-Q1E from the culture medium was a mixture of Glu and Pyr based on MS analysis (two peaks, 11 819 and 11 837 Da) (Fig. 3). 

Phrase: "The N-terminal residue of pelB-derived rOnc-Q1E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1709915:Residue [Conceptual Entity]
   742   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "from inclusion bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0007637:Inclusion Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1512693:Inclusion [Qualitative Concept]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "was"

Phrase: "Glu only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "that of sOnc-Q1E"

Phrase: "from the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "a mixture of Glu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "Pyr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "based on MS analysis"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1524024:analysis [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3152252:Mass [Quantitative Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(two peaks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "11 819"

Phrase: "and"

Phrase: "11 837 Da) (Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.115: These results reveal that the N-terminal Gln of onconase from the E.coli culture media is totally converted into Pyr, whereas the N-terminal Glu of onconase from the culture medium is partially converted to Pyr, probably by some E.coli enzymes under the same culture conditions. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that"

Phrase: "the N-terminal Gln of onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "from the E.coli culture media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   861   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Media [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0162867:Media [Tissue]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1254021:Media [Tissue]
   812   C2242979:Culture [Laboratory Procedure]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "is"

Phrase: "totally"

Phrase: "converted into Pyr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "whereas"

Phrase: "the N-terminal Glu of onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "is"

Phrase: "partially"

Phrase: "converted"

Phrase: "to Pyr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "probably by some E.coli enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0014834:E coli [Bacterium]
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]
   753   C0750492:Probably [Idea or Concept]

Phrase: "under the same culture conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.116: The molecular masses of all the above-mentioned onconase variants are in good agreement with the values calculated from the DNA sequence by the ExPASY server (23) (Fig. 3). 

Phrase: "The molecular masses of all"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   726   C0577559:Mass [Finding]
   726   C1306372:*Mass [Quantitative Concept]

Phrase: "the above-mentioned onconase variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "are in good agreement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with the values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "calculated from the DNA sequence"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1519249:Sequence [Functional Concept]

Phrase: "by the ExPASY server"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0679792:server [Population Group]
   861   C1705194:Server [Manufactured Object]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.117: View larger version (17K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.118: Mass spectrum analysis of onconase variants. 

Phrase: "Mass spectrum analysis of onconase variants."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0037813:Spectrum Analysis, Mass [Laboratory Procedure]
   790   C0037812:Spectrum Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.119: The onconase variant was desalted by a C4 column in 0.3% formic acid and 50% acetonitrile (v/v), and analyzed in a Micromass Q-TOF UltimaTM API spectrometer equipped with an orthogonal electrospray source. 

Phrase: "The onconase variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "was"

Phrase: "desalted by a C4 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]

Phrase: "in 0.3% formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0885348:formic acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "50% acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]

Phrase: "(v/v),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560268:%V/V [Quantitative Concept]
  1000   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "analyzed in a Micromass Q-TOF UltimaTM API spectrometer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0039685:TOF [Congenital Abnormality]
   742   C0183395:Spectrometer [Medical Device]
   742   C0936012:Analyzed [Research Activity]
   742   C1710143:Spectrometer [Manufactured Object]
   742   C1825291:TOF [Gene or Genome]
   742   C2348791:TOF [Quantitative Concept]

Phrase: "equipped with an orthogonal electrospray source."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]
Processing 00000000.tx.120: The abbreviation of each variant is explained in the text. 

Phrase: "The abbreviation of each variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0000723:Abbreviation [Intellectual Product]

Phrase: "is"

Phrase: "explained in the text."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.121: rOnc', rOnc kept in 20 mM sodium phosphate, pH 7.0, at 4C for 2 weeks.  

Phrase: "rOnc',"

Phrase: "rOnc"

Phrase: "kept in 20 mM sodium phosphate,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719   C0333118:Keep [Functional Concept]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 2 weeks."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442457:2 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.122: Structural integrity and antigenicity. 

Phrase: "Structural integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "antigenicity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2698667:ANTIGENICITY [Regulation or Law]
   900 E C0003320:Antigen [Immunologic Factor]
Processing 00000000.tx.123: To see the effects of the N-terminus on the structural integrity, the CD spectra of these rOnc variants were recorded between 190 and 260 nm at pH 7.0 (Fig. 4A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "the effects of the N-terminus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on the structural integrity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "the CD spectra of these rOnc variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded between 190"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0034869:Record [Intellectual Product]

Phrase: "and"

Phrase: "260 nm at pH 7.0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.124: The results indicate that at this resolution the secondary structures of onconase variants are not significantly perturbed by these N-terminal modifications. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that at this resolution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514893:Resolution [Idea or Concept]
   770   C1706463:Resolution [Quantitative Concept]
   770   C2699488:Resolution [Conceptual Entity]

Phrase: "the secondary structures of onconase variants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0162807:Secondary Structure [Spatial Concept]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "perturbed by these N-terminal modifications."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719   C0392747:Modification [Functional Concept]
   719   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.125: As far as thermostability is concerned, sOnc is the most stable (Tm = 92C), followed by rOnc-Q1E (Tm = 89C), rMOnc-Q1S (Tm = 89C), rMOnc-Q1A (Tm = 89C) and rMOnc (Tm = 85C) (Fig. 4B). 

Phrase: "As far as thermostability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597571:thermostability [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "concerned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: ","

Phrase: "sOnc"

Phrase: "is"

Phrase: "the most stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205360:Stable [Qualitative Concept]
   861   C1547311:Stable [Intellectual Product]

Phrase: "(Tm = 92C"

Phrase: ")"

Phrase: ","

Phrase: "followed by rOnc-Q1E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(Tm = 89C"

Phrase: ")"

Phrase: ","

Phrase: "rMOnc-Q1S"

Phrase: "(Tm = 89C"

Phrase: ")"

Phrase: ","

Phrase: "rMOnc-Q1A"

Phrase: "(Tm = 89C"

Phrase: ")"

Phrase: "and"

Phrase: "rMOnc"

Phrase: "(Tm = 85C"

Phrase: ")"

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: The antigenicity of onconase was markedly reduced by the addition of Met, but was slightly altered by Q1A or Q1E mutation at the N-terminus (Fig. 2B). 

Phrase: "The antigenicity of onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced by the addition of Met,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Reduced [Qualitative Concept]
   753   C1883712:Addition [Functional Concept]

Phrase: "but"

Phrase: "was"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "altered by Q1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "Q1E mutation at the N-terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.127: These results suggest that the Pyr1 plays important roles in the structural integrity and the immunogenic epitope of onconase, and is disrupted by Met addition or residue substitution at the N-terminus. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Pyr1"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "important roles in the structural integrity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "the immunogenic epitope of onconase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003316:Epitope [Immunologic Factor]

Phrase: "and"

Phrase: "is"

Phrase: "disrupted by Met addition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332454:Disrupted [Qualitative Concept]
   770   C1883712:Addition [Functional Concept]

Phrase: "or"

Phrase: "residue substitution at the N-terminus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1555721:Substitution [Idea or Concept]
   753   C1706204:Substitution [Activity]
Processing 00000000.tx.128: View larger version (19K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.129: CD spectra and thermostability of onconase variants. 

Phrase: "CD spectra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "and"

Phrase: "thermostability of onconase variants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597571:thermostability [Natural Phenomenon or Process]
Processing 00000000.tx.130: (A) Spectrum analysis. 

Phrase: "(A"

Phrase: ")"

Phrase: "Spectrum analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037812:Spectrum Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.131: CD spectra of 20 M onconase variants in 20 mM sodium phosphate, pH 7.0, were recorded from 190 to 260 nm and presented as mean residue ellipticity and expressed in deg cm2 dmol1. 

Phrase: "CD spectra of 20 M onconase variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "in 20 mM sodium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "were"

Phrase: "recorded from 190"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0034869:Record [Intellectual Product]

Phrase: "to 260 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "presented as mean residue ellipticity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0444504:Mean [Quantitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "and"

Phrase: "expressed in deg cm2 dmol1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439479:cm2 [Quantitative Concept]
   760   C0555206:CM2 [Congenital Abnormality]
   760   C2348088:deg [Quantitative Concept]
Processing 00000000.tx.132: (B) Thermostability. 

Phrase: "(B) Thermostability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597571:thermostability [Natural Phenomenon or Process]
Processing 00000000.tx.133: The equilibrium CD titration experiment was measured at 200 nm as a function of temperature. 

Phrase: "The equilibrium CD titration experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0681814:Experiment [Research Activity]
   804   C1706386:Experiment [Conceptual Entity]
   733 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "measured at 200 nm"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of temperature."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]
Processing 00000000.tx.134: The abbreviation of each variant is explained in the text.  

Phrase: "The abbreviation of each variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0000723:Abbreviation [Intellectual Product]

Phrase: "is"

Phrase: "explained in the text."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.135: Catalytic activity and base specificity. 

Phrase: "Catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "base specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.136: Although members of the RNase A superfamily possess a similar global structure that contains three -helices and two anti-parallel -strands, their substrate specificities are different. 

Phrase: "Although"

Phrase: "members of the RNase A superfamily"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "a similar global structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "three -helices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1017315:helices [Eukaryote]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "and"

Phrase: "two anti-parallel -strands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1704972:Strand [Spatial Concept]
   779   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "their substrate specificities"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificities [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   777 E C0205369:Specific [Qualitative Concept]
   777 E C1552740:specific [Intellectual Product]

Phrase: "are"

Phrase: "different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.137: Onconase and RC-RNase 2 prefer UG, whereas RC-RNase 4 prefers CG. 

Phrase: "Onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "RC-RNase 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0971639:RC-RNase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0525614:RNase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1419366:RC [Gene or Genome]

Phrase: "prefer"

Phrase: "UG,"

Phrase: "whereas"

Phrase: "RC-RNase 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0071795:RNase-4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1419366:RC [Gene or Genome]

Phrase: "prefers"

Phrase: "CG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]
Processing 00000000.tx.138: RC-RNase and RC-RNaseL1 prefer UG and CG, but RNase A prefers both UA and CA (7,10,24,25). 

Phrase: "RC-RNase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "RC-RNaseL1"

Phrase: "prefer"

Phrase: "UG"

Phrase: "and"

Phrase: "CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: "but"

Phrase: "RNase A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prefers"

Phrase: "both UA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041580:UA [Geographic Area]
  1000   C0042014:UA [Laboratory Procedure]

Phrase: "and"

Phrase: "CA (7,"

Phrase: "10,"

Phrase: "24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.139: To determine residues involved in the base specificity and their possible roles in cytotoxicity, mutations were made based on the base specificities and structures of the ribonucleases in the RNase A superfamily. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "involved in the base specificity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0002055:base [Inorganic Chemical]
   760   C0037791:Specificity [Quantitative Concept]
   760   C0178499:Base [Chemical Viewed Functionally]
   760   C1314939:Involved [Functional Concept]
   760   C1511884:Specificity [Quantitative Concept]
   760   C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "their possible roles in cytotoxicity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "based on the base specificities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726   C0037791:Specificity [Quantitative Concept]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726   C1511884:Specificity [Quantitative Concept]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "structures of the ribonucleases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0678594:Structure [Spatial Concept]

Phrase: "in the RNase A superfamily."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883220:Superfamily [Conceptual Entity]
Processing 00000000.tx.140: There are two substrate-binding sites, the B1 and B2 subsites, and one catalytic center, the P1 subsite, in these ribonucleases (25). 

Phrase: "There"

Phrase: "are"

Phrase: "two substrate-binding sites,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1710236:Substrate [Manufactured Object]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "the B1"

Phrase: "and"

Phrase: "B2 subsites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710234:Subsite [Spatial Concept]

Phrase: "and"

Phrase: "one catalytic center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "the P1 subsite,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710234:Subsite [Spatial Concept]

Phrase: "in these ribonucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.141: The Km values of secretory onconase for CG and UG were similar, 47.3 and 50.1 M, respectively, while their kcat values differed substantially, 24.7 and 492.9 min1, respectively. 

Phrase: "The Km values of secretory onconase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "for CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "UG"

Phrase: "were"

Phrase: "similar, 47.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "50.1 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "respectively,"

Phrase: "while"

Phrase: "their kcat values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "differed"

Phrase: "substantially,"

Phrase: "24.7"

Phrase: "and"

Phrase: "492.9 min1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3272448:MIN1 [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.142: These results show that onconase has similar binding affinity for CG and UG, but has a preferential catalytic activity for UG only. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "has"

Phrase: "similar binding affinity for CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "UG,"

Phrase: "but"

Phrase: "has"

Phrase: "a preferential catalytic activity for UG only."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0243102:catalytic activity [Molecular Function]
   778   C1264638:Catalytic activity [Functional Concept]
   778   C1547012:*Catalytic Activity [Quantitative Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.143: We mutated the B1 base-responsible residues Lys33, Thr35 and Asp67, which are equivalent to Val37, Thr39 and Thr70 of RC-RNase, or to Val43, Thr45 and Asp83 of RNase A, respectively. 

Phrase: "We"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "the B1 base-responsible residues Lys33,"

Phrase: "Thr35"

Phrase: "and"

Phrase: "Asp67,"

Phrase: "which"

Phrase: "are"

Phrase: "equivalent to Val37,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205163:Equivalent [Qualitative Concept]
   790   C0439185:equivalent [Quantitative Concept]

Phrase: "Thr39"

Phrase: "and"

Phrase: "Thr70 of RC-RNase,"

Phrase: "or to Val43,"

Phrase: "Thr45"

Phrase: "and"

Phrase: "Asp83 of RNase A,"

Phrase: "respectively."
Processing 00000000.tx.144: The Val37 of RC-RNase has a hydrophobic interaction with the B1 base (26). 

Phrase: "The Val37 of RC-RNase"

Phrase: "has"

Phrase: "a hydrophobic interaction with the B1 base"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0678607:hydrophobic interaction [Molecular Function]
   748   C1704675:Interaction [Functional Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.145: The Onc-K33A and Onc-K33E were less active than sOnc on zymogram (Fig. 5B), but their B1 base specificities remained unchanged (Fig. 5C). 

Phrase: "The Onc-K33A"

Phrase: "and"

Phrase: "Onc-K33E"

Phrase: "were"

Phrase: "less active than sOnc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205177:Active [Functional Concept]

Phrase: "on zymogram"

Phrase: "(Fig. 5B"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "their B1 base specificities"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0037791:Specificity [Quantitative Concept]
   793   C1511884:Specificity [Quantitative Concept]
   743 E C0205369:Specific [Qualitative Concept]
   743 E C1552740:specific [Intellectual Product]

Phrase: "remained"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.146: The non-specific catalytic activity of sOnc-T35A for total RNAs and the kcat/Km values for both CG and UG markedly decreased, 12.2, 4.5 and 0.3%, respectively, compared with that of wild-type onconase (Table 2 and Fig. 5B). 

Phrase: "The non-specific catalytic activity of sOnc-T35A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "for total RNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the kcat/Km values for both CG"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "UG markedly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "12.2,"

Phrase: "4.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450367:4 5 [Quantitative Concept]

Phrase: "and"

Phrase: "0.3%,"

Phrase: "respectively,"

Phrase: "compared with that of wild-type onconase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1547052:*Type [Quantitative Concept]
   748   C1707455:Compared [Activity]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 5B"

Phrase: ")."
Processing 00000000.tx.147: However, the absolute kcat/Km values for both CG and UG are similar, 2.2 x 104 and 2.5 x 104 M1 min1, respectively. 

Phrase: "However,"

Phrase: "the absolute kcat/Km values for both CG"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   750   C0205344:Absolute Value [Qualitative Concept]
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "UG"

Phrase: "are"

Phrase: "similar, 2.2 x 104"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "2.5 x 104 M1 min1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C3272448:MIN1 [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.148: The result shows that the B1 base preference of sOnc-T35A was relaxed from uracil (U) to both U and cytidine (C), while that of sOnc-T35S was still U as seen in sOnc (Table 2 and Fig. 5C). 

Phrase: "The result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the B1 base preference of sOnc-T35A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0558295:preference [Idea or Concept]
   748   C1549513:Preference [Idea or Concept]

Phrase: "was"

Phrase: "relaxed from uracil (U)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035028:Relaxed [Activity]
   790   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   790   C0542193:Relaxed [Qualitative Concept]

Phrase: "to both U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "cytidine (C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "while"

Phrase: "that of sOnc-T35S"

Phrase: "was"

Phrase: "still U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "as"

Phrase: "seen in sOnc"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 5C"

Phrase: ")."
Processing 00000000.tx.149: These results indicate that the hydroxyl group of Thr35 is crucial for B1 base preference and catalytic activity. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the hydroxyl group of Thr35"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   760   C0063146:Hydroxyl [Inorganic Chemical]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "crucial for B1 base preference"

Phrase: "and"

Phrase: "catalytic activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.150: In contrast, the kcat/Km values of D67A for UG markedly decreased, 3.1% left, but its kcat/Km values for CG increased 6-fold and its non-specific catalytic activity for total RNA increased 8-fold compared with that of wild-type onconase. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the kcat/Km values of D67A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "for UG markedly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "3.1% left,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: "but"

Phrase: "its kcat/Km values for CG"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "its non-specific catalytic activity for total RNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "compared with that of wild-type onconase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1547052:*Type [Quantitative Concept]
   748   C1707455:Compared [Activity]
Processing 00000000.tx.151: However, its absolute kcat/Km value for CG (315 x 104 M1 min1) was 10-fold higher than that for UG (30.7 x 104 M1 min1). 

Phrase: "However,"

Phrase: "its absolute kcat/Km value for CG (315 x 104 M1 min1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0205344:Absolute Value [Qualitative Concept]
   736   C1522609:Value [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "10-fold higher than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "for UG"

Phrase: "(30.7 x 104 M1 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C3272448:MIN1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.152: The change of B1 base preference of sOnc-D67A from U to C was also observed by RNA cleavage analysis on an 18mer RNA (Fig. 5C). 

Phrase: "The change of B1 base preference of sOnc-D67A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0025320:The change [Physiologic Function]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "from U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "to C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "also"

Phrase: "observed by RNA cleavage analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C3178791:RNA Cleavage [Molecular Function]
   797   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0010813:cleavage [Cell Function]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C0936012:Analysis [Research Activity]
   760   C1330957:cleavage [Cell Function]
   760   C1441672:Observed [Functional Concept]
   760   C1524024:analysis [Functional Concept]

Phrase: "on an 18mer RNA (Fig. 5C"

Phrase: ")."
Processing 00000000.tx.153: The relaxation of B1 base specificity from U to cytosine (C) and U was found in sOnc-D67T by similar analyses (Table 2 and Fig. 5C). 

Phrase: "The relaxation of B1 base specificity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035028:Relaxation [Activity]

Phrase: "from U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "to cytosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010843:Cytosine [Biologically Active Substance,Organic Chemical]

Phrase: "(C"

Phrase: ")"

Phrase: "and"

Phrase: "U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "was"

Phrase: "found in sOnc-D67T"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "by similar analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 5C"

Phrase: ")."
Processing 00000000.tx.154: These results indicate that residue 67 also participates in B1 base recognition: Asp prefers U, Ala prefers C and Thr prefers both C and U. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that residue 67 also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "participates in B1 base recognition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002055:base [Inorganic Chemical]
   760   C0178499:Base [Chemical Viewed Functionally]
   760   C0524637:Recognition [Mental Process]
   760   C1880279:Base [Biomedical or Dental Material]

Phrase: ":"

Phrase: "Asp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206293:Asp [Reptile]
  1000   C3541260:ASP [Gene or Genome]

Phrase: "prefers"

Phrase: "U,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "Ala"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   907 E C0043189:Wing [Body Part, Organ, or Organ Component]

Phrase: "prefers"

Phrase: "C"

Phrase: "and"

Phrase: "Thr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "prefers"

Phrase: "both C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "U."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.155: View larger version (58K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(58K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.156: Analysis of residues involved in catalytic activity and base specificity. 

Phrase: "Analysis of residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "involved in catalytic activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0243102:catalytic activity [Molecular Function]
   833   C1264638:Catalytic activity [Functional Concept]
   833   C1547012:*Catalytic Activity [Quantitative Concept]
   770   C0007382:Catalytic [Natural Phenomenon or Process]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "base specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.157: (A) SDSPAGE analysis. 

Phrase: "(A"

Phrase: ")"

Phrase: "SDSPAGE analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.158: One microgram of purified ribonucleases was separated by 13.3% SDSPAGE and stained by Coomassie blue. 

Phrase: "One microgram of purified ribonucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439211:microgram [Quantitative Concept]

Phrase: "was"

Phrase: "separated by 13.3% SDSPAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "stained by Coomassie blue."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.159: (B) Zymogram. 

Phrase: "(B) Zymogram."
Processing 00000000.tx.160: A purified onconase variant (0.2 g) was subjected to RNA-casting SDSPAGE and Toluidine blue O staining. 

Phrase: "A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "onconase variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "(0.2 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "subjected to RNA-casting SDSPAGE"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0179686:Cast [Medical Device]
   726   C0302143:Cast [Body Substance]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "Toluidine blue O staining."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0523203:Toluidine blue O staining [Laboratory Procedure]
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]
   756   C0040380:Toluidine Blue O [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   708   C0046584:toluidine o [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.161: (C) Base specificity of ribonuclease. 

Phrase: "(C"

Phrase: ")"

Phrase: "Base specificity of ribonuclease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.162: 5' End-labeled oligoribonucleotide was partially (approximately one fourth) digested with ribonuclease as indicated, in 50 mM sodium acetate, pH 6.0, 50 mM sodium chloride and 0.1 g/l bovine serum albumin, at 30C for 10 min. 

Phrase: "5' End-labeled oligoribonucleotide"

Phrase: "was"

Phrase: "partially"

Phrase: "(approximately one fourth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205438:Fourth [Quantitative Concept]
   827   C1706303:Fourth [Qualitative Concept]

Phrase: ")"

Phrase: "digested with ribonuclease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0868946:digested [Physiologic Function]

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "in 50 mM sodium acetate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 6.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50 mM sodium chloride"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0037494:Sodium Chloride [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0596019:Chloride [Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1 g/l bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   818   C0728877:serum albumin [Laboratory or Test Result]
   795   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0007452:Bovine [Mammal]
   795   C0229671:Serum [Body Substance]
   795   C1140701:bovine [Mammal]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]

Phrase: "at 30C"

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.163: These products were separated by 8 M urea15% PAGE and visualized by autoradiography. 

Phrase: "These products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by 8 M urea15% PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0126577:M-8 [Organic Chemical,Pharmacologic Substance]
   753   C0086972:Separated [Finding]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.164: The abbreviation of each ribonuclease is explained in the text. 

Phrase: "The abbreviation of each ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0000723:Abbreviation [Intellectual Product]

Phrase: "is"

Phrase: "explained in the text."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.165: The cleavage bonds are shown in the right margin.  

Phrase: "The cleavage bonds"

Phrase: "are"

Phrase: "shown in the right margin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205090:Right [Spatial Concept]
   760   C0205284:Margin [Spatial Concept]
   760   C0229985:margin [Body Part, Organ, or Organ Component]
   760   C1269830:Margin [Finding]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.166: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.167: Catalytic activities and cytotoxicities of onconase and its mutants  With regard to the B2 base specificity, it is known that Asn71 and Glu111 of RNase A are involved in B2 base recognition. 

Phrase: "Catalytic activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C0243102:catalytic activity [Molecular Function]
   983   C1264638:Catalytic activity [Functional Concept]
   983   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cytotoxicities of onconase"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   756   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   706 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   706 E C1511636:cytotoxic [Functional Concept]

Phrase: "and"

Phrase: "its mutants  With regard to the B2 base specificity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "it"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that Asn71"

Phrase: "and"

Phrase: "Glu111 of RNase A"

Phrase: "are"

Phrase: "involved in B2 base recognition."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0002055:base [Inorganic Chemical]
   760   C0178499:Base [Chemical Viewed Functionally]
   760   C0507114:B2 [Body Part, Organ, or Organ Component]
   760   C0524637:Recognition [Mental Process]
   760   C1314939:Involved [Functional Concept]
   760   C1416271:B2 [Gene or Genome]
   760   C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.168: The RNase A Glu111-equivalent residue in onconase is Glu91, but there is no Asn71-equivalent residue. 

Phrase: "The RNase A Glu111-equivalent residue in onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1709915:Residue [Conceptual Entity]
   744   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "is"

Phrase: "Glu91,"

Phrase: "but"

Phrase: "there"

Phrase: "is"

Phrase: "no Asn71-equivalent residue."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.169: The kcat/Km values of sOnc-E91A for CG (3.0% left) and UG (2.9% left) markedly decreased, but its non-specific catalytic activity only decreased slightly (68.5% left) (Table 2). 

Phrase: "The kcat/Km values of sOnc-E91A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "for CG (3.0% left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205091:Left [Spatial Concept]
   812   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "UG"

Phrase: "(2.9% left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "its non-specific catalytic activity only"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0243102:catalytic activity [Molecular Function]
   840   C1264638:Catalytic activity [Functional Concept]
   840   C1547012:*Catalytic Activity [Quantitative Concept]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "(68.5% left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: This suggests that some bases other than guanine (G) in the B2 site may be recognized by sOnc-E91A. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "some"

Phrase: "bases other than guanine (G)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002055:base [Inorganic Chemical]
   770   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0178499:Base [Chemical Viewed Functionally]
   770   C1626935:Bases [Quantitative Concept]
   770   C1880279:Base [Biomedical or Dental Material]

Phrase: "in the B2 site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "recognized by sOnc-E91A."
Processing 00000000.tx.171: In fact, the B2 base specificity of sOnc-E91A was relaxed from G to adenine (A), G and U because the CA, UA and UU bonds on the 18mer oligoribonucleotide are cleaved (Fig. 5C). 

Phrase: "In fact,"

Phrase: "the B2 base specificity of sOnc-E91A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "was"

Phrase: "relaxed from G"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0035028:Relaxed [Activity]
   790   C0542193:Relaxed [Qualitative Concept]

Phrase: "to adenine (A),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "because"

Phrase: "the CA,"

Phrase: "UA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041580:UA [Geographic Area]
  1000   C0042014:UA [Laboratory Procedure]

Phrase: "and"

Phrase: "UU bonds on the 18mer oligoribonucleotide"

Phrase: "are"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.172: The Lys95 and Glu97 residues are involved in the B2 base specificity of RC-RNase. 

Phrase: "The Lys95"

Phrase: "and"

Phrase: "Glu97 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "involved in the B2 base specificity of RC-RNase."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   742   C0002055:base [Inorganic Chemical]
   742   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0037791:Specificity [Quantitative Concept]
   742   C0178499:Base [Chemical Viewed Functionally]
   742   C0507114:B2 [Body Part, Organ, or Organ Component]
   742   C1314939:Involved [Functional Concept]
   742   C1416271:B2 [Gene or Genome]
   742   C1419366:RC [Gene or Genome]
   742   C1511884:Specificity [Quantitative Concept]
   742   C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.173: Their equivalents in onconase are Thr89 and Glu91, respectively (26). 

Phrase: "Their equivalents in onconase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439185:Equivalents [Quantitative Concept]
   737 E C0205163:Equivalent [Qualitative Concept]

Phrase: "are"

Phrase: "Thr89"

Phrase: "and"

Phrase: "Glu91,"

Phrase: "respectively"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.174: The kcat/Km values of sOnc-T89K for both CG and UG reduced (5.1 and 20.2% left, respectively), but its non-specific catalytic activity increased up to 5-fold. 

Phrase: "The kcat/Km values of sOnc-T89K"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "for both CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "UG"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(5.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "20.2% left,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "its non-specific catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0243102:catalytic activity [Molecular Function]
   861   C1264638:Catalytic activity [Functional Concept]
   861   C1547012:*Catalytic Activity [Quantitative Concept]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "increased up to 5-fold."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205217:Increased [Quantitative Concept]
   760   C0332462:Fold [Spatial Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.175: Thus, we suspect that the enhancement of catalytic activity in sOnc-T89K may be due to the relaxation of B2 base specificity, similar to that of sOnc-E91A. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "suspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750491:suspect [Idea or Concept]
  1000   C1571873:Suspect [Idea or Concept]

Phrase: "that"

Phrase: "the enhancement of catalytic activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1707919:Enhanced Activity [Quantitative Concept]
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "in sOnc-T89K"

Phrase: "may"

Phrase: "be due to the relaxation of B2 base specificity,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0002055:base [Inorganic Chemical]
   742   C0035028:Relaxation [Activity]
   742   C0037791:Specificity [Quantitative Concept]
   742   C0178499:Base [Chemical Viewed Functionally]
   742   C0507114:B2 [Body Part, Organ, or Organ Component]
   742   C1416271:B2 [Gene or Genome]
   742   C1511884:Specificity [Quantitative Concept]
   742   C1880279:Base [Biomedical or Dental Material]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]

Phrase: "similar to that of sOnc-E91A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.176: With regard to the N-terminal variants, the non-specific catalytic activity of sOnc was the highest (100%), then nOnc (96.8%), rMOnc-Q1A (57.1%), rOnc (26.4%), rMOnc-Q1S (20.6%), sOnc-Q1E (14.6%), rOnc-Q1E (0.9%), sMOnc-Q1S (0.8%) and rMOnc (0.5%) (Table 2). 

Phrase: "With regard to the N-terminal variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "the non-specific catalytic activity of sOnc"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0243102:catalytic activity [Molecular Function]
   778   C1264638:Catalytic activity [Functional Concept]
   778   C1547012:*Catalytic Activity [Quantitative Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "the highest"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C1522410:Highest [Qualitative Concept]
   966 E C0205250:High [Qualitative Concept]
   966 E C1299351:High [Qualitative Concept]
   966 E C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "(100%"

Phrase: ")"

Phrase: ","

Phrase: "then nOnc"

Phrase: "(96.8%"

Phrase: ")"

Phrase: ","

Phrase: "rMOnc-Q1A"

Phrase: "(57.1%"

Phrase: ")"

Phrase: ","

Phrase: "rOnc"

Phrase: "(26.4%"

Phrase: ")"

Phrase: ","

Phrase: "rMOnc-Q1S"

Phrase: "(20.6%"

Phrase: ")"

Phrase: ","

Phrase: "sOnc-Q1E"

Phrase: "(14.6%"

Phrase: ")"

Phrase: ","

Phrase: "rOnc-Q1E"

Phrase: "(0.9%"

Phrase: ")"

Phrase: ","

Phrase: "sMOnc-Q1S"

Phrase: "(0.8%"

Phrase: ")"

Phrase: "and"

Phrase: "rMOnc"

Phrase: "(0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: The catalytic activity of sQ1E-Onc isolated from culture media (14.6%) is higher than that of rOnc-Q1E refolded from inclusion bodies (0.9%) because the N-terminal Glu is partially converted into Pyr during or before secretion into the culture medium (Fig. 3). 

Phrase: "The catalytic activity of sQ1E-Onc"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0243102:catalytic activity [Molecular Function]
   790   C1264638:Catalytic activity [Functional Concept]
   790   C1547012:*Catalytic Activity [Quantitative Concept]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "isolated from culture media"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   833   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Media [Intellectual Product]
   770   C0010453:Culture [Idea or Concept]
   770   C0162867:Media [Tissue]
   770   C0205409:Isolated [Functional Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C1254021:Media [Tissue]
   770   C1548221:Isolated [Idea or Concept]
   770   C2242979:Culture [Laboratory Procedure]
   737 E C0370215:Isolate [Substance]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "(14.6%"

Phrase: ")"

Phrase: "is"

Phrase: "higher than that of rOnc-Q1E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "refolded from inclusion bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0007637:Inclusion Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1512693:Inclusion [Qualitative Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "(0.9%"

Phrase: ")"

Phrase: "because"

Phrase: "the N-terminal Glu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "partially"

Phrase: "converted into Pyr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "during"

Phrase: "or before secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]

Phrase: "into the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.178: The difference in catalytic activity among these N-terminal variants may be due to the relaxation of base specificity in rMOnc-Q1A and rMOnc-Q1S, but not in rOnc-Q1E, similar to the N-terminal variants of RC-RNase (26). 

Phrase: "The difference in catalytic activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "among these N-terminal variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "may"

Phrase: "be due to the relaxation of base specificity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0002055:base [Inorganic Chemical]
   744   C0035028:Relaxation [Activity]
   744   C0037791:Specificity [Quantitative Concept]
   744   C0178499:Base [Chemical Viewed Functionally]
   744   C1511884:Specificity [Quantitative Concept]
   744   C1880279:Base [Biomedical or Dental Material]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "in rMOnc-Q1A"

Phrase: "and"

Phrase: "rMOnc-Q1S,"

Phrase: "but"

Phrase: "not in rOnc-Q1E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]

Phrase: "similar to the N-terminal variants of RC-RNase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.179: The Km values of rMOnc-Q1A for CG (11.3 M) and UG (19.4 M) decreased as compared with that of wild-type onconase (47.3 and 50.1 M, respectively). 

Phrase: "The Km values of rMOnc-Q1A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "for CG (11.3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0622367:CG 11 [Organic Chemical]
   827   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3540479:CG [Gene or Genome]

Phrase: "M)"

Phrase: "and"

Phrase: "UG"

Phrase: "(19.4"

Phrase: "M)"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "as"

Phrase: "compared with that of wild-type onconase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1547052:*Type [Quantitative Concept]
   748   C1707455:Compared [Activity]

Phrase: "(47.3"

Phrase: "and"

Phrase: "50.1 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.180: Similarly, the values of rMOnc-Q1S for CG (27.9 M) and UG (17.1 M) also decreased. 

Phrase: "Similarly,"

Phrase: "the values of rMOnc-Q1S"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "for CG (27.9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3540479:CG [Gene or Genome]

Phrase: "M)"

Phrase: "and"

Phrase: "UG"

Phrase: "(17.1"

Phrase: "M)"

Phrase: "also"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.181: These results show that the replacement of N-terminal Pyr by Ala or Ser may increase its affinity for CG and UG through B2 G, but does not enhance its catalytic activity. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the replacement of N-terminal Pyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035139:Replacement [Therapeutic or Preventive Procedure]
   753   C0559956:Replacement [Functional Concept]
   753   C1555302:Replacement [Idea or Concept]

Phrase: "by Ala"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   907 E C0043189:Wing [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "Ser"

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "its affinity for CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "UG through B2 G,"

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "its catalytic activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.182: The recombinant onconase, rOnc, refolded from inclusion bodies had nearly the same base specificity as that of sOnc, UG > CG, while Met-tagged variants, sMOnc-Q1S and rMOnc, cleaved not only CG and UG but also CA, UA and UU bonds on the cleavage sites on 18mer RNA (Fig. 5C). 

Phrase: "The recombinant onconase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "rOnc,"

Phrase: "refolded from inclusion bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0007637:Inclusion Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1512693:Inclusion [Qualitative Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "had"

Phrase: "nearly"

Phrase: "the same base specificity as that of sOnc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037791:Specificity [Quantitative Concept]
   744   C1511884:Specificity [Quantitative Concept]

Phrase: "UG"

Phrase: "> CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: "while"

Phrase: "Met-tagged variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "sMOnc-Q1S"

Phrase: "and"

Phrase: "rMOnc,"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "not only CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "UG"

Phrase: "but"

Phrase: "also CA,"

Phrase: "UA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041580:UA [Geographic Area]
  1000   C0042014:UA [Laboratory Procedure]

Phrase: "and"

Phrase: "UU bonds on the cleavage sites"

Phrase: "on 18mer RNA (Fig. 5C"

Phrase: ")."
Processing 00000000.tx.183: These results indicate that the B2 base specificity of onconase is relaxed from G to A, G and U by Met addition or some residue substitutions at the N-terminus. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the B2 base specificity of onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "is"

Phrase: "relaxed from G"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0035028:Relaxed [Activity]
   790   C0542193:Relaxed [Qualitative Concept]

Phrase: "to A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "U by Met addition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "or"

Phrase: "some residue substitutions at the N-terminus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1555721:Substitution [Idea or Concept]
   714   C1706204:Substitution [Activity]
Processing 00000000.tx.184: Cytotoxicities towards tumor cells. 

Phrase: "Cytotoxicities towards tumor cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   761   C0022686:Cytotoxic cell [Cell]
   737   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
Processing 00000000.tx.185: We have determined the cytotoxicity of onconase on five cell lines: human cervical carcinoma HeLa S-3 cells (IC50 = 0.2 M), human leukemia K562 cells (IC50 = 1 M), bovine aortic endothelial cells BAEC (IC50 = 1 M), human breast cancer MCF-7 cells (IC50 > 8 M) and normal human fibroblast cells HFW (IC50 >> 8 M). 

Phrase: "We"

Phrase: "have"

Phrase: "determined"

Phrase: "the cytotoxicity of onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "on five cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ":"

Phrase: "human cervical carcinoma HeLa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018873:HeLa [Cell]

Phrase: "S-"

Phrase: "3 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(IC50 = 0.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "human leukemia K562 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0600432:K562 Cells [Cell]
   822   C1517806:Leukemic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(IC50 = 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "bovine aortic endothelial cells BAEC (IC50 = 1"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   818   C0225336:Endothelial Cells [Cell]
   795   C0003483:Aortic [Body Part, Organ, or Organ Component]
   795   C0007452:Bovine [Mammal]
   795   C0007634:Cells [Cell]
   795   C0014257:Endothelial [Tissue]
   795   C0600495:IC50 [Quantitative Concept]
   795   C1140701:bovine [Mammal]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "M)"

Phrase: ","

Phrase: "human breast cancer MCF-7 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   903   C1512505:Human Breast Cancer Cell [Cell]
           Breast Cancer Cell
   895   C0427861:Human cells [Laboratory or Test Result]
   861   C0596890:MCF-7 Cells [Cell]
   858   C0334227:cancer cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(IC50 > 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "and"

Phrase: "normal human fibroblast cells HFW"

Phrase: "(IC50 >> 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)."
Processing 00000000.tx.186: We then examined the cytotoxicity of N-terminal variants on HeLa S-3 cells. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the cytotoxicity of N-terminal variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "on HeLa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018873:HeLa [Cell]

Phrase: "S-"

Phrase: "3 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.187: The cytotoxicities of rOnc-Q1E (IC50 = 4 M) and rMOnc-Q1S (IC50 = 4 M) were slightly less than that of rOnc (IC50 = 1.5 M), while that of rMOnc-Q1A (IC50 > 8 M) was much less than that of rOnc, although its non-specific catalytic activity (57.1%) is higher than that of rOnc (26.4%). 

Phrase: "The cytotoxicities of rOnc-Q1E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "(IC50 = 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "and"

Phrase: "rMOnc-Q1S"

Phrase: "(IC50 = 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "were"

Phrase: "slightly less than that of rOnc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750482:Slightly [Idea or Concept]

Phrase: "(IC50 = 1.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "while"

Phrase: "that of rMOnc-Q1A"

Phrase: "(IC50 > 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "was"

Phrase: "much less than that of rOnc,"

Phrase: "although"

Phrase: "its non-specific catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0243102:catalytic activity [Molecular Function]
   861   C1264638:Catalytic activity [Functional Concept]
   861   C1547012:*Catalytic Activity [Quantitative Concept]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(57.1%"

Phrase: ")"

Phrase: "is"

Phrase: "higher than that of rOnc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "(26.4%"

Phrase: ")."
Processing 00000000.tx.188: The cytotoxicity was almost obliterated by the Met addition at the N-terminus, e.g. 

Phrase: "The cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "was"

Phrase: "almost"

Phrase: "obliterated by the Met addition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0700134:Obliterated [Functional Concept]
   760   C1883712:Addition [Functional Concept]

Phrase: "at the N-terminus,"

Phrase: "e.g."
Processing 00000000.tx.189: sMOnc-Q1S (IC50 >> 8 M) and rMOnc (IC50 >> 8 M) (Fig. 6A and Table 2). 

Phrase: "sMOnc-Q1S"

Phrase: "(IC50 >> 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "and"

Phrase: "rMOnc"

Phrase: "(IC50 >> 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M) ("

Phrase: "Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "and"

Phrase: "Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.190: These results show that the Pyr1 of onconase plays a crucial role in the cytotoxicity as well as the catalytic activity; 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Pyr1 of onconase"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a crucial role in the cytotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "as well as"

Phrase: "the catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.191: part of the cytotoxicity was retained if Pyr1 was substituted with Ser or Glu, although their specific catalytic activities for UG markedly decreased (4.7 and 1.0% left, respectively). 

Phrase: "part of the cytotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "was"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "if"

Phrase: "Pyr1"

Phrase: "was"

Phrase: "substituted with Ser"

Phrase: "or"

Phrase: "Glu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "although"

Phrase: "their specific catalytic activities for UG markedly"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   762   C0243102:catalytic activity [Molecular Function]
   762   C1264638:Catalytic activity [Functional Concept]
   762   C1547012:*Catalytic Activity [Quantitative Concept]
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(4.7"

Phrase: "and"

Phrase: "1.0% left,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.192: View larger version (24K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.193: Analysis of the cytotoxicity of onconase variants on HeLa S-3 cells. 

Phrase: "Analysis of the cytotoxicity of onconase variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "on HeLa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018873:HeLa [Cell]

Phrase: "S-"

Phrase: "3 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.194: HeLa S-3 cells (3 x 103) were seeded on a 96-well plate overnight and incubated with onconase variants for 72 h (six wells per treatment). 

Phrase: "HeLa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018873:HeLa [Cell]

Phrase: "S-"

Phrase: "3 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(3 x 103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "seeded on a 96-well plate"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0005971:Plate [Medical Device]
   753   C0205170:Well [Qualitative Concept]
   753   C1139930:plate [Medical Device]
   753   C3146287:Well [Manufactured Object]
   753   C3537155:Plate [Manufactured Object]
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "incubated with onconase variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0205419:variants [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "for 72 h (six wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0205170:Well [Qualitative Concept]
   779   C3146287:Well [Manufactured Object]

Phrase: "per treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.195: The survival rates of onconase-treated cells were determined by ATP Lite-M and expressed as a percentage. 

Phrase: "The survival rates of onconase-treated cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0038954:Survival Rates [Quantitative Concept]
   757   C0007620:Cell Survival [Cell Function]
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "determined by ATP Lite-M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "expressed as a percentage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.196: (A) N-terminal variants of onconase. 

Phrase: "(A"

Phrase: ")"

Phrase: "N-terminal variants of onconase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.197: (B) B1 and B2 base variants of onconase.  

Phrase: "(B) B1"

Phrase: "and"

Phrase: "B2 base variants of onconase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.198: The effects of B1 and B2 base specificity on cytotoxicity of onconases were also examined. 

Phrase: "The effects of B1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "B2 base specificity on cytotoxicity of onconases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.199: The cytotoxicities of sOnc-T35A (IC50 > 8 M) and sOnc-E91A (IC50 = 7 M) decreased with the loss of non-specific catalytic activity for total RNAs (12.2 and 68.5% left, respectively) and specific activity for the innate substrate UG (0.3 and 2.9% left, respectively). 

Phrase: "The cytotoxicities of sOnc-T35A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "(IC50 > 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "and"

Phrase: "sOnc-E91A"

Phrase: "(IC50 = 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "decreased with the loss of non-specific catalytic activity"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   764   C0205370:Non-specific [Qualitative Concept]
   764   C0243102:catalytic activity [Molecular Function]
   764   C1264638:Catalytic activity [Functional Concept]
   764   C1547012:*Catalytic Activity [Quantitative Concept]
   762   C0086439:Decreased activity [Sign or Symptom]
   742   C0007382:Catalytic [Natural Phenomenon or Process]
   742   C0205177:Activity [Functional Concept]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0205369:Specific [Qualitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0442797:decreased [Qualitative Concept]
   742   C1517945:Loss [Quantitative Concept]
   742   C1518422:Non [Functional Concept]
   742   C1552740:specific [Intellectual Product]
   742   C1561536:*Activity [Idea or Concept]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: "for total RNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(12.2"

Phrase: "and"

Phrase: "68.5% left,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "and"

Phrase: "specific activity for the innate substrate UG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205177:Activity [Functional Concept]
   748   C0205369:Specific [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1552740:specific [Intellectual Product]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(0.3"

Phrase: "and"

Phrase: "2.9% left,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.200: However, the cytotoxicity of sOnc-D67A (IC50 = 4 M) decreased with the reduction of specific catalytic activity for UG (3.1% left), although it had an 8-fold increase in non-specific catalytic activity (Table 2 and Fig. 6B). 

Phrase: "However,"

Phrase: "the cytotoxicity of sOnc-D67A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "(IC50 = 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "decreased with the reduction of specific catalytic activity"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   767   C0086439:Decreased activity [Sign or Symptom]
   767   C2267000:Reduction Activity [Molecular Function]
   744   C0007382:Catalytic [Natural Phenomenon or Process]
   744   C0205177:Activity [Functional Concept]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0205369:Specific [Qualitative Concept]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Decreased [Qualitative Concept]
           Reduction
   744   C0439167:% activity [Quantitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C0441655:Activity [Activity]
   744   C0442797:decreased [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]
   744   C1561536:*Activity [Idea or Concept]
   711 E C0547047:Decrease [Quantitative Concept]

Phrase: "for UG"

Phrase: "(3.1% left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "it"

Phrase: "had"

Phrase: "an 8-fold increase in non-specific catalytic activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 6B"

Phrase: ")."
Processing 00000000.tx.201: These results reveal that the catalytic activity for the innate substrate UG is required for the cytotoxicity of onconase, but non-specific catalytic activity towards total RNAs is not sufficient to enhance its cytotoxicity.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that"

Phrase: "the catalytic activity for the innate substrate UG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "required for the cytotoxicity of onconase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   753   C1514873:Required [Functional Concept]
   753   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "but"

Phrase: "non-specific catalytic activity towards total RNAs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0243102:catalytic activity [Molecular Function]
   778   C1264638:Catalytic activity [Functional Concept]
   778   C1547012:*Catalytic Activity [Quantitative Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "its cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.202: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Ribonucleases possessing cytotoxicity towards tumor cells are predominantly found in the oocytes of frog, which have Pyr at the N-terminus, prefer pyrimidineguanine RNA substrates, demonstrate high thermostability and are not neutralized by the ribonuclease inhibitor from human placenta (712). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ribonucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "cytotoxicity towards tumor cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   767   C0022686:Cytotoxic cell [Cell]

Phrase: "are"

Phrase: "predominantly"

Phrase: "found in the oocytes of frog,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0003459:Frog [Amphibian]
   753   C0029045:Oocytes [Cell]
   753   C0034650:Frog [Amphibian]
   753   C0150312:Found [Quantitative Concept]
   753   C1527389:Frog, NOS [Amphibian]
   719 E C0243095:Find [Finding]

Phrase: "which"

Phrase: "have"

Phrase: "Pyr at the N-terminus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "prefer"

Phrase: "pyrimidineguanine RNA substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "demonstrate"

Phrase: "high thermostability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597571:thermostability [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "neutralized by the ribonuclease inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C3539761:Ribonuclease Inhibitor [Amino Acid, Peptide, or Protein]
   760   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "from human placenta"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0032043:Placenta [Embryonic Structure]
   861   C1278988:Placenta [Embryonic Structure]
   861   C1550656:Placenta [Body Substance]
   789 E C0230956:Placental [Mammal]

Phrase: "(712"

Phrase: ")."
Processing 00000000.tx.203: We are interested in the roles of N-terminal Pyr on the frogs cytotoxicity. 

Phrase: "We"

Phrase: "are"

Phrase: "interested in the roles of N-terminal Pyr"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0035820:Roles [Social Behavior]
   744   C0205088:Terminal [Temporal Concept]
   744   C0543488:Interested [Mental Process]
   744   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   711 E C1705810:Role [Conceptual Entity]

Phrase: "on the frogs cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.204: Based on the computation of 27 000 curated (NP) and putative (XP) protein sequence entries from the NCBI RefSeq database using the SignalP program for the prediction of signal peptides and cleavage sites (27,28), it is known that 12.3% of proteins with signal peptides are initiated with Gln at the N-terminus after the signal peptide is removed. 

Phrase: "Based on the computation of 27 000 curated"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C1880157:Computation [Activity]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711   C1707535:Curate [Activity]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(NP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706141:NP [Gene or Genome]

Phrase: "and"

Phrase: "putative"

Phrase: "(XP) protein sequence entries from the NCBI RefSeq database"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1705654:Entry [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SignalP program for the prediction of signal peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1709697:Program [Conceptual Entity]
   742   C2728259:Program [Pharmacologic Substance]
   742   C3484370:Program [Functional Concept]

Phrase: "and"

Phrase: "cleavage sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that 12.3% of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with signal peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037081:Signal Peptides [Amino Acid Sequence]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "initiated with Gln"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C1548602:Initiate [Idea or Concept]
   756   C1704686:Initiate [Functional Concept]

Phrase: "at the N-terminus"

Phrase: "after the signal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037081:Signal Peptide [Amino Acid Sequence]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.205: The resultant N-terminal Gln is converted to Pyr by deamination, which is usually essential for the biological functions of many proteins and hormones (29,30). 

Phrase: "The resultant N-terminal Gln"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "converted"

Phrase: "to Pyr by deamination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "which"

Phrase: "is"

Phrase: "usually essential for the biological functions of many proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.206: With respect to the N-terminal Pyr in ribonucleases, the N-terminal Pyr of human RNase 4 or RNase 5 is structurally flexible and is not involved in catalytic activity (31,32). 

Phrase: "With respect to the N-terminal Pyr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "in ribonucleases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the N-terminal Pyr of human RNase 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "RNase 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0051844:RNase-5 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "structurally flexible"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0443220:Flexible [Qualitative Concept]
   789 E C0242808:Flexibility [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in catalytic activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0243102:catalytic activity [Molecular Function]
   833   C1264638:Catalytic activity [Functional Concept]
   833   C1547012:*Catalytic Activity [Quantitative Concept]
   770   C0007382:Catalytic [Natural Phenomenon or Process]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.207: Pyr is also found at the N-termini of most mouse ribonucleases, but its function is still not clear (33). 

Phrase: "Pyr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "is"

Phrase: "also"

Phrase: "found at the N-termini of most mouse ribonucleases,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0150312:Found [Quantitative Concept]
   708 E C0243095:Find [Finding]

Phrase: "but"

Phrase: "its function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "still"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.208: Pyr is found at the N-termini of all known frog ribonucleases and both catalytic activity and cytotoxicity were markedly reduced if Met was added to the N-terminus of frog ribonuclease, i.e. onconase from R.pipiens and RC-RNase 4 from R.catesbeiana (15,34). 

Phrase: "Pyr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "is"

Phrase: "found at the N-termini of all known frog ribonucleases"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   739   C0003459:Frog [Amphibian]
   739   C0034650:Frog [Amphibian]
   739   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0150312:Found [Quantitative Concept]
   739   C0205309:Known [Qualitative Concept]
   739   C1527389:Frog, NOS [Amphibian]
   706 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "both catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "were"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "if"

Phrase: "Met"

Phrase: "was"

Phrase: "added to the N-terminus of frog ribonuclease,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0003459:Frog [Amphibian]
   744   C0034650:Frog [Amphibian]
   744   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1524062:Added [Functional Concept]
   744   C1527389:Frog, NOS [Amphibian]
   711 E C1883712:Add [Functional Concept]

Phrase: "i.e. onconase from R.pipiens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "RC-RNase 4 from R.catesbeiana"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0071795:RNase-4 [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0658605:RNase R [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205090:R- [Spatial Concept]
   753   C0684010:R. [Professional or Occupational Group]
   753   C1419366:RC [Gene or Genome]
   753   C2603358:R' [Clinical Attribute]

Phrase: "(15,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.209: The role of Pyr1 on the catalytic activity and cytotoxicity of frog ribonuclease could be further investigated by biophysical studies. 

Phrase: "The role of Pyr1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "on the catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cytotoxicity of frog ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "could"

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated by biophysical studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0005553:Biophysical [Biomedical Occupation or Discipline]
   770   C0947630:studies [Laboratory Procedure]
   770   C1292732:investigated [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.210: From our previous study, three hydrogen bonds exerted by Pyr1 are observed in the RC-RNased(ACGA) complex (26). 

Phrase: "From our previous study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "three hydrogen bonds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0020276:hydrogen bond [Natural Phenomenon or Process]
   827   C0020275:Hydrogen [Element, Ion, or Isotope]
   827   C0523702:HYDROGEN [Laboratory Procedure]
   827   C0885426:hydrogen [Inorganic Chemical]

Phrase: "exerted by Pyr1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015264:Exerted [Organism Function]

Phrase: "are"

Phrase: "observed in the RC-RNased"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1419366:RC [Gene or Genome]
   760   C1441672:Observed [Functional Concept]

Phrase: "(ACGA"

Phrase: ")"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.211: First, the O of Pyr1 binds to Lys9, which further hydrogen bonds to the catalytic phosphate, and the Lys9 is also bound to the side chain amide of Asn38 and the hydroxyl group of Tyr28 by hydrogen bonds. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the O of Pyr1"

Phrase: "binds to Lys9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "which further hydrogen bonds to the catalytic phosphate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0020276:bonds hydrogen [Natural Phenomenon or Process]
   744   C0020275:Hydrogen [Element, Ion, or Isotope]
   744   C0523702:HYDROGEN [Laboratory Procedure]
   744   C0885426:hydrogen [Inorganic Chemical]

Phrase: "and"

Phrase: "the Lys9"

Phrase: "is"

Phrase: "also"

Phrase: "bound to the side chain amide of Asn38"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0002482:Amide [Organic Chemical]
   744   C0332297:bound [Spatial Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C0441987:Side [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1524075:Chain [Idea or Concept]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "the hydroxyl group of Tyr28"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   760   C0063146:Hydroxyl [Inorganic Chemical]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "by hydrogen bonds."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0020276:hydrogen bond [Natural Phenomenon or Process]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.212: Secondly, the N of Pyr1 binds to Val102, which further hydrogen bonds to Lys95 which interacts with the B2 substrate G. 

Phrase: "Secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "the N of Pyr1"

Phrase: "binds to Val102,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "which further hydrogen bonds to Lys95"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0020276:bonds hydrogen [Natural Phenomenon or Process]
   753   C0020275:Hydrogen [Element, Ion, or Isotope]
   753   C0523702:HYDROGEN [Laboratory Procedure]
   753   C0885426:hydrogen [Inorganic Chemical]

Phrase: "which"

Phrase: "interacts with the B2 substrate G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0507114:B2 [Body Part, Organ, or Organ Component]
   753   C1416271:B2 [Gene or Genome]
   753   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.213: Thirdly, the O of Pyr1 directly binds to the N2 amine of the substrate G. 

Phrase: "Thirdly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Thirdly [Quantitative Concept]

Phrase: "the O of Pyr1 directly"

Phrase: "binds to the N2 amine of the substrate G."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0002508:Amine [Organic Chemical]
   742   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0441960:N2 [Finding]
   742   C1145667:Bind [Activity]
   742   C1167622:bind [Molecular Function]
   742   C1710236:Substrate [Manufactured Object]
   742   C1879694:Amine [Organic Chemical]
Processing 00000000.tx.214: The hydrogen bond network contributed by these residues at different -helices, -strands and loops is able to strengthen the structural integrity of ribonuclease, e.g. 

Phrase: "The hydrogen bond network"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]
   734   C0020276:hydrogen bond [Natural Phenomenon or Process]

Phrase: "contributed by these residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1709915:Residue [Conceptual Entity]
   737   C1880177:Contribute [Activity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "at different -helices, -"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1017315:helices [Eukaryote]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1704972:Strand [Spatial Concept]
   966   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "loops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0181687:loops [Medical Device]
   966 E C0419518:Loop [Medical Device]
   966 E C0445022:Loop [Spatial Concept]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "strengthen"

Phrase: "the structural integrity of ribonuclease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "e.g."
Processing 00000000.tx.215: Pyr1 (1), Lys9 (1), Val96 (6), Tyr28 (loop 2), Asn38 (1) and Lys95 (5) in RC-RNase. 

Phrase: "Pyr1"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "Lys9"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "Val96"

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "Tyr28"

Phrase: "(loop 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "Asn38"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "Lys95"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "in RC-RNase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.216: In native onconase, two hydrogen bonds exerted by Pyr1 are bound to Lys9 and Val96, equivalent to Lys9 and Val102 of RC-RNase (26,35). 

Phrase: "In native onconase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "two hydrogen bonds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0020276:hydrogen bond [Natural Phenomenon or Process]
   827   C0020275:Hydrogen [Element, Ion, or Isotope]
   827   C0523702:HYDROGEN [Laboratory Procedure]
   827   C0885426:hydrogen [Inorganic Chemical]

Phrase: "exerted by Pyr1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015264:Exerted [Organism Function]

Phrase: "are"

Phrase: "bound to Lys9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "Val96,"

Phrase: "equivalent to Lys9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205163:Equivalent [Qualitative Concept]
   790   C0439185:equivalent [Quantitative Concept]

Phrase: "and"

Phrase: "Val102 of RC-RNase"

Phrase: "(26,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.217: In this study, we found that the thermostability (7C reduction in Tm), catalytic activity (0.50.9% left) and cytotoxicity (IC50 >> 8 M) were severely reduced by Met addition at the N-terminus. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the thermostability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597571:thermostability [Natural Phenomenon or Process]

Phrase: "(7C reduction in Tm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(0.50.9% left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205091:Left [Spatial Concept]
   812   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "(IC50 >> 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "were"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "reduced by Met addition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Reduced [Qualitative Concept]
   770   C1883712:Addition [Functional Concept]

Phrase: "at the N-terminus."
Processing 00000000.tx.218: The thermostabilities of all the Pyr1-substitutional variants slightly reduced (3C reduction in Tm), but their specific catalytic activities for the innate substrate UG markedly reduced (1.04.7% left). 

Phrase: "The thermostabilities of all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0597571:thermostability [Natural Phenomenon or Process]

Phrase: "the Pyr1-substitutional variants slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(3C reduction in Tm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "their specific catalytic activities for the innate substrate UG markedly"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   743   C0243102:catalytic activity [Molecular Function]
   743   C1264638:Catalytic activity [Functional Concept]
   743   C1547012:*Catalytic Activity [Quantitative Concept]
   739   C0441655:Activities [Activity]
   706 E C0205177:Activity [Functional Concept]
   706 E C0439167:% activity [Quantitative Concept]
   706 E C1561536:*Activity [Idea or Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(1.04.7% left"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205091:Left [Spatial Concept]
   812   C1552822:left [Functional Concept]
   708   C3541329:1-7 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.219: However, their cytotoxicities towards HeLa S-3 cells varied, e.g. 

Phrase: "However,"

Phrase: "their cytotoxicities towards HeLa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "S-"

Phrase: "3 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "varied"

Phrase: ","

Phrase: "e.g."
Processing 00000000.tx.220: rMOnc-Q1A (IC50 > 8 M), rMOnc-Q1S (IC50 = 4 M), rMOnc-Q1E (IC50 = 4 M), even if the non-specific catalytic activity of rMOnc-Q1A (57.1%) is higher than that of rMOnc-Q1S (20.6%) and rMOnc-Q1E (0.9%). 

Phrase: "rMOnc-Q1A"

Phrase: "(IC50 > 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "rMOnc-Q1S"

Phrase: "(IC50 = 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "rMOnc-Q1E"

Phrase: "(IC50 = 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "even"

Phrase: "if"

Phrase: "the non-specific catalytic activity of rMOnc-Q1A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(57.1%"

Phrase: ")"

Phrase: "is"

Phrase: "higher than that of rMOnc-Q1S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(20.6%"

Phrase: ")"

Phrase: "and"

Phrase: "rMOnc-Q1E"

Phrase: "(0.9%"

Phrase: ")."
Processing 00000000.tx.221: It has been shown by DiDonatos group that Met addition at the N-terminus markedly decreases the catalytic activity for total RNAs and the cytotoxicity towards tumor cells, but only slightly reduces its conformation stability and resistance against pepsin digestion. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown by DiDonatos group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C1547282:Show [Intellectual Product]

Phrase: "that Met addition at the N-terminus markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1883712:Addition [Functional Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the catalytic activity for total RNAs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0243102:catalytic activity [Molecular Function]
   790   C1264638:Catalytic activity [Functional Concept]
   790   C1547012:*Catalytic Activity [Quantitative Concept]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the cytotoxicity towards tumor cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   745   C0022686:Cytotoxic cell [Cell]

Phrase: "but"

Phrase: "only slightly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0750482:Slightly [Idea or Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "reduces"

Phrase: "its conformation stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "resistance against pepsin digestion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
Processing 00000000.tx.222: The depletion of the fourth disulfide bridge (Cys87Cys104) markedly decreases the stability of the protein, but does not significantly reduce its catalytic activity and cytotoxicity (36). 

Phrase: "The depletion of the fourth disulfide bridge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333668:Depletion [Functional Concept]

Phrase: "(Cys87Cys104"

Phrase: ")"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the stability of the protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2350440:Protein Stability [Qualitative Concept]
   760   C0205360:Stability [Qualitative Concept]
   760   C2347098:Stability [Qualitative Concept]

Phrase: "but"

Phrase: "does"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "its catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.223: Rybaks group has shown that rM1Onc-E1S and rM1Onc-E1Y restore significant catalytic activities and cytotoxicities from that of rM1Onc, and become susceptible to human ribonuclease inhibitor. 

Phrase: "Rybaks group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that rM1Onc-E1S"

Phrase: "and"

Phrase: "rM1Onc-E1Y"

Phrase: "restore"

Phrase: "significant catalytic activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C0243102:catalytic activity [Molecular Function]
   884   C1264638:Catalytic activity [Functional Concept]
   884   C1547012:*Catalytic Activity [Quantitative Concept]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cytotoxicities from that of rM1Onc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "become"

Phrase: "susceptible to human ribonuclease inhibitor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231204:Susceptible [Functional Concept]
   760   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.224: They suggested that the hydroxyl group of Ser or Tyr behind Met is crucial for the catalytic activity and cytotoxicity of onconase (37). 

Phrase: "They"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the hydroxyl group of Ser"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   760   C0063146:Hydroxyl [Inorganic Chemical]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "or"

Phrase: "Tyr behind Met"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1421250:TYR [Gene or Genome]

Phrase: "is"

Phrase: "crucial for the catalytic activity"

Phrase: "and"

Phrase: "cytotoxicity of onconase"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   718 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   718 E C1511636:cytotoxic [Functional Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.225: In this study, we prepared a sMOnc-Q1S with MetSerAspTrpAla at the N-terminus and found that both catalytic activity and cytotoxicity are similar to that of rMOnc, which are much less than that of wild-type onconase. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "a sMOnc-Q1S with MetSerAspTrpAla"

Phrase: "at the N-terminus"

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "both catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "are"

Phrase: "similar to that of rMOnc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "much less than that of wild-type onconase."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.226: Therefore, we prepared the rMOnc-Q1S from inclusion bodies without the pelB signal peptide using the method as described by Rybaks group for the production of rM1Onc-E1S and rM1Onc-E1Y (37), and found that the rM1Onc-E1S has a significant increase in catalytic activity and cytotoxicity (Table 2 and Fig. 6A). 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "the rMOnc-Q1S from inclusion bodies"

Phrase: "without the pelB signal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037081:Signal Peptide [Amino Acid Sequence]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "as"

Phrase: "described by Rybaks group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552738:described [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "for the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of rM1Onc-E1S"

Phrase: "and"

Phrase: "rM1Onc-E1Y"

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the rM1Onc-E1S"

Phrase: "has"

Phrase: "a significant increase in catalytic activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.227: After the MS and Edman degradation analyses, we found the N-terminal residue of rM1Onc-E1S is Ser rather than Met, as expected (Fig. 3). 

Phrase: "After the MS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0231290:After [Temporal Concept]
   812   C0577559:Mass [Finding]
   812   C0687676:After [Temporal Concept]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]
   741   C0037805:Spectrophotometry [Laboratory Procedure]

Phrase: "and"

Phrase: "Edman degradation analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "the N-terminal residue of rM1Onc-E1S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "is"

Phrase: "Ser"

Phrase: "rather than"

Phrase: "Met,"

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.228: Therefore, we suggest that the hydrogen bond network mainly contributed by N-terminal Pyr is able to maintain the structural integrity for specific catalytic activity for UG and cytotoxicity towards tumor cells, while the disulfide bridges linking -strands distant from the catalytic center do not possess these functions. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the hydrogen bond network mainly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1513822:Network [Professional or Occupational Group]
   812   C1705739:Network [Manufactured Object]
   812   C1882071:Network [Conceptual Entity]

Phrase: "contributed by N-terminal Pyr"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205088:Terminal [Temporal Concept]
   760   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   726   C1880177:Contribute [Activity]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the structural integrity for specific catalytic activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205266:integrity [Qualitative Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1947912:Integrity [Qualitative Concept]

Phrase: "for UG"

Phrase: "and"

Phrase: "cytotoxicity towards tumor cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   767   C0022686:Cytotoxic cell [Cell]

Phrase: "while"

Phrase: "the disulfide bridges linking -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]

Phrase: "strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "distant from the catalytic center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443203:Distant [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "these functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.229: In addition, a hydrogen bond network similar to that exerted by Pyr may be formed by Ser or Glu, but not by Ala substitution or Met addition at the N-terminus. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a hydrogen bond network"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]
   734   C0020276:hydrogen bond [Natural Phenomenon or Process]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "exerted by Pyr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015264:Exerted [Organism Function]
   790   C0600319:Pyroglutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "may"

Phrase: "be"

Phrase: "formed by Ser"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0205431:Formed [Functional Concept]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]
   756 E C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "Glu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "not by Ala substitution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1518422:Not [Functional Concept]
   770   C1555721:Substitution [Idea or Concept]
   770   C1706204:Substitution [Activity]

Phrase: "or"

Phrase: "Met addition at the N-terminus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]
Processing 00000000.tx.230: The Met preceding the Ser of rMOnc-Q1S and the Ala of rMOnc-Q1A was removed, while the Met at the N-termini of rMOnc, rMOnc-Q1E and rMOnc-Q1Y in inclusion bodies and the sMOnc-Q1S in the culture medium was retained. 

Phrase: "The Met preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332152:Preceding [Temporal Concept]

Phrase: "the Ser of rMOnc-Q1S"

Phrase: "and"

Phrase: "the Ala of rMOnc-Q1A"

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "while"

Phrase: "the"

Phrase: "Met at the N-termini of rMOnc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1550543:Meet [Idea or Concept]

Phrase: "rMOnc-Q1E"

Phrase: "and"

Phrase: "rMOnc-Q1Y in inclusion bodies"

Phrase: "and"

Phrase: "the sMOnc-Q1S in the culture medium"

Phrase: "was"

Phrase: "retained."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]
Processing 00000000.tx.231: The in vivo removal of Met from the small and uncharged penultimate residue, i.e. 

Phrase: "The in vivo removal of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "Met from the small"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0700321:Small [Quantitative Concept]
   737   C1550543:Meet [Idea or Concept]

Phrase: "and"

Phrase: "uncharged penultimate residue,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.232: Ala and Ser, may be mediated through an E.coli methionine aminopeptidase inside the cell, which is unable to remove the Met from the bulky or charge penultimate residue, such as Gln, Glu and Tyr residues (38). 

Phrase: "Ala"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   907 E C0043189:Wing [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Ser,"

Phrase: "may"

Phrase: "be"

Phrase: "mediated through an E.coli methionine aminopeptidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0014834:E coli [Bacterium]
   778   C0127863:Methionine aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0002570:Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "inside the cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the"

Phrase: "Met from the bulky"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1550543:Meet [Idea or Concept]

Phrase: "or"

Phrase: "charge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007961:Charge [Quantitative Concept]
  1000   C1706211:Charge [Organism Attribute]

Phrase: "penultimate residue,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "such as Gln,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Glu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Tyr residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.233: The Met preceding the Gln of wild-type onconase was not removable by the enzyme except when the mutation occurs at the penultimate residue, e.g. 

Phrase: "The Met preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332152:Preceding [Temporal Concept]

Phrase: "the Gln of wild-type onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "not removable by the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882925:Removable [Qualitative Concept]

Phrase: "except"

Phrase: "when"

Phrase: "the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occurs at the penultimate residue,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1709305:Occur [Activity]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "e.g."
Processing 00000000.tx.234: Q1A or Q1S mutation; 

Phrase: "Q1A"

Phrase: "or"

Phrase: "Q1S mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.235: however, these mutations usually cause a significant reduction in thermostability and cytotoxicity compared with the wild type. 

Phrase: "however,"

Phrase: "these mutations usually"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a significant reduction in thermostability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "compared with the wild type."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.236: In this study, we expressed the onconase gene from genomic DNA rather than from the synthetic or semi-synthetic onconase gene in E.coli and produced various N-terminal variants through the pelB signal peptide without treatment with cyanogen bromide or Aeromonas proteolytica aminopeptidase (15,31,37). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "expressed"

Phrase: "the onconase gene from genomic DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Gene [Gene or Genome]

Phrase: "rather than from the synthetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883254:synthetic [Activity]

Phrase: "or"

Phrase: "semi-synthetic onconase gene in E.coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017374:Synthetic Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "produced various N-terminal variants through the pelB signal peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205419:variants [Qualitative Concept]

Phrase: "without treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with cyanogen bromide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010511:Cyanogen Bromide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0056658:cyanogen [Hazardous or Poisonous Substance,Inorganic Chemical]

Phrase: "or"

Phrase: "Aeromonas proteolytica aminopeptidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1805463:Aeromonas proteolytica aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
           Aeromonas aminopeptidase
   827   C0002570:Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0318269:Aeromonas proteolytica [Bacterium]

Phrase: "(15,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.237: Consequently, the method employed here, using the pelB signal peptide, is able to produce recombinant proteins with any amino acid residue at the N-terminus. 

Phrase: "Consequently,"

Phrase: "the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "here,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the pelB signal peptide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037081:Signal Peptide [Amino Acid Sequence]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "produce"

Phrase: "recombinant proteins with any amino acid residue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C1874187:acid amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   778   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1514798:recombinant [Organism]

Phrase: "at the N-terminus."
Processing 00000000.tx.238: The base preferences for pyrimidine (C, U) and G in the B1 and B2 sites, respectively, are the unique properties of frog cytotoxic ribonuclease, whereas those for respective pyrimidine (C, U) and A are found in most mammalian ribonucleases. 

Phrase: "The base preferences for pyrimidine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0558295:Preferences [Idea or Concept]
   726 E C1549513:Preference [Idea or Concept]

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "G in the B1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "B2 sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "respectively,"

Phrase: "are"

Phrase: "the unique properties of frog cytotoxic ribonuclease,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "whereas"

Phrase: "those for respective pyrimidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034284:Pyrimidine [Organic Chemical]
   770   C0034289:Pyrimidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "found in most mammalian ribonucleases."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0024660:Mammalian [Mammal]
   760   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.239: In this study, we found that the hydroxyl group of Thr35 of onconase is essential for pyrimidine recognition and Asp67 is crucial for U recognition at the B1 site because sOnc-T35A and sOnc-D67T recognized both C and U at the B1 site, while sOnc-D67A preferred C in contrast to U of wild-type onconase (Fig. 5C). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the hydroxyl group of Thr35 of onconase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   748   C0063146:Hydroxyl [Inorganic Chemical]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "essential for pyrimidine recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "Asp67"

Phrase: "is"

Phrase: "crucial for U recognition"

Phrase: "at the B1 site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "because"

Phrase: "sOnc-T35A"

Phrase: "and"

Phrase: "sOnc-D67T"

Phrase: "recognized"

Phrase: "both C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "U at the B1 site,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "while"

Phrase: "sOnc-D67A"

Phrase: "preferred"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0558295:Preferred [Idea or Concept]
  1000   C1548789:Preferred [Qualitative Concept]
  1000   C3543840:Preferred [Qualitative Concept]

Phrase: "C in contrast to U of wild-type onconase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.240: These results are in good agreement with the structure of the RC-RNased(ACGA) complex. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in good agreement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "of the RC-RNased"

Phrase: "(ACGA"

Phrase: ")"

Phrase: "complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.241: RC-RNase is a ribonuclease isolated from R.catesbeiana, which prefers both C and U at the B1 site. 

Phrase: "RC-RNase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "isolated from R.catesbeiana,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205090:R- [Spatial Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0684010:R. [Professional or Occupational Group]
   770   C1548221:Isolated [Idea or Concept]
   770   C2603358:R' [Clinical Attribute]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "which"

Phrase: "prefers"

Phrase: "both C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "U at the B1 site."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.242: The hydroxyl group of Thr39 serves as a hydrogen bond donor for the N3 of cytosine (C) and simultaneously serves as a hydrogen bond acceptor from the hydroxyl group of Thr70. 

Phrase: "The hydroxyl group of Thr39"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   760   C0063146:Hydroxyl [Inorganic Chemical]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "serves as a hydrogen bond donor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0020276:hydrogen bond [Natural Phenomenon or Process]
   753   C0013018:Donor [Population Group]
   753   C0020275:Hydrogen [Element, Ion, or Isotope]
   753   C0040288:Donor [Population Group]
   753   C0523702:HYDROGEN [Laboratory Procedure]
   753   C0885426:hydrogen [Inorganic Chemical]
   753   C1527169:Donor NOS [Finding]

Phrase: "for the N3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441961:N3 [Finding]

Phrase: "of cytosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010843:Cytosine [Biologically Active Substance,Organic Chemical]

Phrase: "(C"

Phrase: ")"

Phrase: "and"

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "serves as a hydrogen bond acceptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020276:hydrogen bond [Natural Phenomenon or Process]
   753   C0000901:acceptor [Population Group]
   753   C0020275:Hydrogen [Element, Ion, or Isotope]
   753   C0523702:HYDROGEN [Laboratory Procedure]
   753   C0885426:hydrogen [Inorganic Chemical]

Phrase: "from the hydroxyl group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   861   C0063146:Hydroxyl [Inorganic Chemical]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "of Thr70."
Processing 00000000.tx.243: In contrast, the hydroxyl group of Thr39 may serve as a hydrogen bond acceptor from U and as a hydrogen donor for Thr70. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the hydroxyl group of Thr39"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   760   C0063146:Hydroxyl [Inorganic Chemical]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "may"

Phrase: "serve as a hydrogen bond acceptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020276:hydrogen bond [Natural Phenomenon or Process]
   753   C0000901:acceptor [Population Group]
   753   C0020275:Hydrogen [Element, Ion, or Isotope]
   753   C0523702:HYDROGEN [Laboratory Procedure]
   753   C0885426:hydrogen [Inorganic Chemical]

Phrase: "from U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and as a hydrogen donor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0013018:Donor [Population Group]
   760   C0020275:Hydrogen [Element, Ion, or Isotope]
   760   C0040288:Donor [Population Group]
   760   C0523702:HYDROGEN [Laboratory Procedure]
   760   C0885426:hydrogen [Inorganic Chemical]
   760   C1515981:And [Idea or Concept]
   760   C1527169:Donor NOS [Finding]

Phrase: "for Thr70."
Processing 00000000.tx.244: The corresponding residues Thr39 and Thr70 of RC-RNase in onconase are Thr35 and Asp67 (26). 

Phrase: "The corresponding residues Thr39"

Phrase: "and"

Phrase: "Thr70 of RC-RNase"

Phrase: "in onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "are"

Phrase: "Thr35"

Phrase: "and"

Phrase: "Asp67"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.245: Therefore, we suggest that the carboxyl group of Asp67 of onconase serves as a distal hydrogen bond acceptor from U through the hydroxyl group of Thr35, but not as a distal hydrogen bond donor for C. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the carboxyl group of Asp67 of onconase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0596260:Carboxyl Group [Organic Chemical]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "serves as a distal hydrogen bond acceptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0020276:hydrogen bond [Natural Phenomenon or Process]
   748   C0000901:acceptor [Population Group]
   748   C0020275:Hydrogen [Element, Ion, or Isotope]
   748   C0205108:Distal [Spatial Concept]
   748   C0523702:HYDROGEN [Laboratory Procedure]
   748   C0885426:hydrogen [Inorganic Chemical]

Phrase: "from U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "through the hydroxyl group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   861   C0063146:Hydroxyl [Inorganic Chemical]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "of Thr35,"

Phrase: "but"

Phrase: "not as a distal hydrogen bond donor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0020276:hydrogen bond [Natural Phenomenon or Process]
   748   C0013018:Donor [Population Group]
   748   C0020275:Hydrogen [Element, Ion, or Isotope]
   748   C0040288:Donor [Population Group]
   748   C0205108:Distal [Spatial Concept]
   748   C0523702:HYDROGEN [Laboratory Procedure]
   748   C0885426:hydrogen [Inorganic Chemical]
   748   C1518422:Not [Functional Concept]
   748   C1527169:Donor NOS [Finding]

Phrase: "for C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.246: The B1 base preference of onconase for U is similar to human RNase 4, which also possesses Thr44 and Asp80 and respective hydrogen bonds at the corresponding sites (32). 

Phrase: "The B1 base preference of onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0558295:preference [Idea or Concept]
   753   C1549513:Preference [Idea or Concept]

Phrase: "for U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "is"

Phrase: "similar to human RNase 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "which also"

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "Thr44"

Phrase: "and"

Phrase: "Asp80"

Phrase: "and"

Phrase: "respective hydrogen bonds at the corresponding sites"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0020276:bonds hydrogen [Natural Phenomenon or Process]
   748   C0020275:Hydrogen [Element, Ion, or Isotope]
   748   C0523702:HYDROGEN [Laboratory Procedure]
   748   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.247: Despite having 105-fold differences in relative ribonucleolytic activity, several members of the RNase A superfamily manifest other biological activities, e.g. human EDN and ECP possess neurotoxicity, and human angiogenin induces blood vessel formation (35). 

Phrase: "Despite"

Phrase: "having"

Phrase: "105-fold differences in relative ribonucleolytic activity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "several members of the RNase A superfamily"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "manifest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "other biological activities,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "e.g. human EDN"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   923   C0059409:Eosinophil-Derived Neurotoxin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   923   C1419408:EOSINOPHIL-DERIVED NEUROTOXIN [Gene or Genome]
   812   C0014467:eosinophil [Cell]
   812   C0027934:Neurotoxin [Hazardous or Poisonous Substance]
   812   C0086418:Human [Human]
   812   C1441547:Derived [Qualitative Concept]
   812   C3245521:derived [Idea or Concept]
   741 E C0333930:Eosinophilic [Functional Concept]
   712 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   712 E C1306759:Eosinophilia [Disease or Syndrome]
   712 E C1636667:Eosinophilia [Disease or Syndrome]
   712 E C2240374:Eosinophilia [Finding]

Phrase: "and"

Phrase: "ECP"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0950373:Eosinophil cationic protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1419409:EOSINOPHIL CATIONIC PROTEIN [Gene or Genome]
   827   C0014467:eosinophil [Cell]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755   C0007447:Cation [Chemical Viewed Structurally]
   755 E C0333930:Eosinophilic [Functional Concept]
   727 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   727 E C1306759:Eosinophilia [Disease or Syndrome]
   727 E C1636667:Eosinophilia [Disease or Syndrome]
   727 E C2240374:Eosinophilia [Finding]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "neurotoxicity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "human angiogenin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0051844:angiogenin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1367482:ANGIOGENIN [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "blood vessel formation"
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   901   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   901   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   901   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   845 E C1558950:VASCULAR [Finding]
   845 E C1801960:Vascular [Qualitative Concept]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   817 E C0005767:Blood [Tissue]
   817 E C0005768:blood [Body Substance]
   817 E C0229664:Blood [Body Substance]
   817 E C0392895:Bloods [Population Group]
   795 E C0333275:Bloody [Qualitative Concept]
   771 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.248: The relationship between catalytic activity and biological function remains unclear; 

Phrase: "The relationship between catalytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "biological function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0031845:Biological function, NOS [Physiologic Function]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0031843:function [Physiologic Function]
   861   C0205460:biological [Qualitative Concept]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "remains"

Phrase: "unclear"

Phrase: ";"
Processing 00000000.tx.249: much effort has been expended on this subject, but the results are still debatable. 

Phrase: "much effort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Effort [Organism Function]

Phrase: "has"

Phrase: "been"

Phrase: "expended on this subject,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "but"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "still debatable."
Processing 00000000.tx.250: For example, alkylation at the ribonuclease active site simultaneously eliminates both ribonuclease and neurotoxic activity of EDN, ECP and onconase (39,40). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "alkylation at the ribonuclease active site simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002074:Alkylation [Natural Phenomenon or Process]

Phrase: "eliminates"

Phrase: "both ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurotoxic activity of EDN,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1152940:neurotoxin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "ECP"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0950373:Eosinophil cationic protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1419409:EOSINOPHIL CATIONIC PROTEIN [Gene or Genome]
   827   C0014467:eosinophil [Cell]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755   C0007447:Cation [Chemical Viewed Structurally]
   755 E C0333930:Eosinophilic [Functional Concept]
   727 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   727 E C1306759:Eosinophilia [Disease or Syndrome]
   727 E C1636667:Eosinophilia [Disease or Syndrome]
   727 E C2240374:Eosinophilia [Finding]

Phrase: "and"

Phrase: "onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069919:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1522172:Onconase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.251: The mutation of the catalytic residue, e.g. 

Phrase: "The mutation of the catalytic residue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "e.g."
Processing 00000000.tx.252: H103A, abolishes both catalytic activity and cytotoxicity of RC-RNase (13). 

Phrase: "H103A,"

Phrase: "abolishes"

Phrase: "both catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cytotoxicity of RC-RNase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.253: On the other hand, the antiparasitic activity and the antibacterial activity of ECP appears to be unaffected by the presence of the ribonuclease inhibitor or the mutation of the catalytic residue (41). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the antiparasitic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the antibacterial activity of ECP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0279516:Antibacterial [Antibiotic]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "unaffected by the presence of the ribonuclease inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2986417:Unaffected [Conceptual Entity]

Phrase: "or"

Phrase: "the mutation of the catalytic residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.254: In this study, we found that the structural integrity and catalytic activity for innate UG exerted by Pyr1 are required for the cytotoxicity, but the non-specific catalytic activity for total RNAs is not sufficient to enhance the cytotoxicity. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the structural integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "catalytic activity for innate UG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0243102:catalytic activity [Molecular Function]
   806   C1264638:Catalytic activity [Functional Concept]
   806   C1547012:*Catalytic Activity [Quantitative Concept]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "exerted by Pyr1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015264:Exerted [Organism Function]

Phrase: "are"

Phrase: "required for the cytotoxicity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   770   C1514873:Required [Functional Concept]

Phrase: "but"

Phrase: "the non-specific catalytic activity for total RNAs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.255: Therefore, we suggest that RNAs with nude UG sequence may be susceptible to internalized onconase in tumor cells, but resistant to mammalian ribonucleases which prefer a pyrimidineadenine substrate.  

Phrase: "Therefore,"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that RNAs with nude UG sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0162327:RNA Sequence [Nucleotide Sequence]
   753   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "be"

Phrase: "susceptible to internalized onconase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "in tumor cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "resistant to mammalian ribonucleases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "which"

Phrase: "prefer"

Phrase: "a pyrimidineadenine substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.256: ACKNOWLEDGEMENTS  We thank Drs Chen-Pei Tu and Victor Lee Weaver for critical reading of the manuscript, Mr Te-Tsui Lee for the computation and statistical analyses of the N-terminal residues of proteins and the Core Facilities for Proteomic Research, Institute of Biological Chemistry, Academia Sinica, for the analyses of amino acid sequences and mass spectra. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs Chen-Pei Tu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1532464:TU [Quantitative Concept]
   812   C2700314:TU [Fish]

Phrase: "and"

Phrase: "Victor Lee Weaver for critical reading of the manuscript,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0326812:Weaver [Bird]

Phrase: "Mr Te-Tsui Lee for the computation"

Phrase: "and"

Phrase: "statistical analyses of the N-terminal residues of proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0871424:statistical analysis [Research Activity]
   728   C1514534:Protein Analysis [Molecular Biology Research Technique]
   708   C0002778:Analysis [Laboratory Procedure]
   708   C0936012:Analysis [Research Activity]
   708   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "the Core Facilities for Proteomic Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0598009:Research Facilities [Manufactured Object]
   773   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   719   C1547538:Facility [Idea or Concept]

Phrase: "Institute of Biological Chemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Academia Sinica,"

Phrase: "for the analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "of amino acid sequences"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0202406:Acid [Laboratory Procedure]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "mass spectra."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0037813:Mass Spectrum [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.257: This work was supported in part by Academia Sinica, the National Science Council of the Republic of China (NSC89-2311-B-001-083) and National Health Research Institute (NHRI-CN-PL-91019).  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by Academia Sinica,"

Phrase: "the National Science Council of the Republic of China"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1551807:Council [Population Group]

Phrase: "(NSC89-2311-B-001-083"

Phrase: ")"

Phrase: "and"

Phrase: "National Health Research Institute"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0027468:national health institute [Health Care Related Organization]
   861   C0035172:Research Institute [Organization]
   812   C0018684:Health [Idea or Concept]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   712 E C0031206:healthiness [Finding]

Phrase: "(NHRI-CN-PL-91019"

Phrase: ")."
Processing 00000000.tx.258: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  DAlessio,G. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "DAlessio,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.259: (1993) New and cryptic biological messages from RNases. 

Phrase: "(1993"

Phrase: ")"

Phrase: "New"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205314:New [Temporal Concept]

Phrase: "and"

Phrase: "cryptic biological messages from RNases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470166:messages [Intellectual Product]
Processing 00000000.tx.260: Trends Cell Biol., 3, 106109.[CrossRef] Blackburn,P. and Moore,S. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "106109."

Phrase: "[CrossRef"

Phrase: "] Blackburn,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.261: (1982) Pancreatic ribonuclease. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Pancreatic ribonuclease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035541:Pancreatic ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1419407:RIBONUCLEASE, PANCREATIC [Gene or Genome]
   861   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.262: In Boyer,P.D. 

Phrase: "In Boyer,"

Phrase: "P.D."
Processing 00000000.tx.263: (ed.), The Enzymes, 3rd Edn. 

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "The Enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "3rd Edn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419408:EDN [Gene or Genome]
Processing 00000000.tx.264: Academic Press, New York, NY, Vol. 

Phrase: "Academic Press,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.265: 15, pp. 

Phrase: "15,"

Phrase: "pp."
Processing 00000000.tx.266: 317433. 

Phrase: "317433."
Processing 00000000.tx.267: Shapiro,R., Riordan,J.F. and Vallee,B.L. 

Phrase: "Shapiro,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Riordan,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Vallee,"

Phrase: "B.L."
Processing 00000000.tx.268: (1986) Characteristic ribonucleolytic activity of human angiogenin. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Characteristic ribonucleolytic activity of human angiogenin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0020115:Human Activity [Activity]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.269: Biochemistry, 25, 35273532.[ISI][Medline] Gleich,G.J., Loegering,D.A., Bell,M.P., Chekel,J.L., Ackerman,S.J. and McKean,D.J. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "25,"

Phrase: "35273532."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gleich,"

Phrase: "G.J.,"

Phrase: "Loegering,"

Phrase: "D."

Phrase: "A.,"

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chekel,"

Phrase: "J.L., Ackerman,"

Phrase: "S."

Phrase: "J."

Phrase: "and"

Phrase: "McKean,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.270: (1986) Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "functional similarities between human eosinophil-derived neurotoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "eosinophil cationic protein"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0950373:Eosinophil cationic protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1419409:EOSINOPHIL CATIONIC PROTEIN [Gene or Genome]
   827   C0014467:eosinophil [Cell]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755   C0007447:Cation [Chemical Viewed Structurally]
   755 E C0333930:Eosinophilic [Functional Concept]
   727 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   727 E C1306759:Eosinophilia [Disease or Syndrome]
   727 E C1636667:Eosinophilia [Disease or Syndrome]
   727 E C2240374:Eosinophilia [Finding]

Phrase: ":"

Phrase: "homology with ribonuclease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1334043:Homology [Gene or Genome]
   790   C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.271: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.272: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.273: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.274: USA, 83, 31463150.[Abstract] Gullberg,U., Widerner,B., Arnason,U., Egesten,A. and Olsson,I. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "83,"

Phrase: "31463150."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gullberg,"

Phrase: "U.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "Widerner,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Arnason,"

Phrase: "U.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041917:Uracil [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "Egesten,"

Phrase: "A."

Phrase: "and"

Phrase: "Olsson,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.275: (1986) The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity. 

Phrase: "(1986"

Phrase: ")"

Phrase: "The cytotoxic eosinophil cationic protein"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   923   C0950373:Eosinophil cationic protein [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1419409:EOSINOPHIL CATIONIC PROTEIN [Gene or Genome]
   812   C0014467:eosinophil [Cell]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0007447:Cation [Chemical Viewed Structurally]
   741 E C0333930:Eosinophilic [Functional Concept]
   712 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   712 E C1306759:Eosinophilia [Disease or Syndrome]
   712 E C1636667:Eosinophilia [Disease or Syndrome]
   712 E C2240374:Eosinophilia [Finding]

Phrase: "(ECP"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0950373:Eosinophil cationic protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1419409:EOSINOPHIL CATIONIC PROTEIN [Gene or Genome]
   827   C0014467:eosinophil [Cell]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755   C0007447:Cation [Chemical Viewed Structurally]
   755 E C0333930:Eosinophilic [Functional Concept]
   727 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   727 E C1306759:Eosinophilia [Disease or Syndrome]
   727 E C1636667:Eosinophilia [Disease or Syndrome]
   727 E C2240374:Eosinophilia [Finding]

Phrase: ")"

Phrase: "has"

Phrase: "ribonuclease activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148840:ribonuclease activity [Genetic Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.276: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.277: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.278: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.279: Commun., 139, 12391242.[ISI][Medline] Vescia,S., Tramontano,D., Augusti-Tocco,G. and DAlessio,G. 

Phrase: "Commun.,"

Phrase: "139,"

Phrase: "12391242."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vescia,"

Phrase: "S."

Phrase: ","

Phrase: "Tramontano,"

Phrase: "D."

Phrase: ","

Phrase: "Augusti-Tocco,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "DAlessio,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.280: (1980) In vitro studies on selective inhibition of tumors cell growth by seminal ribonuclease. 

Phrase: "(1980"

Phrase: ")"

Phrase: "In vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "studies on selective inhibition of tumors cell growth"
Meta Candidates (Total=25; Excluded=2; Pruned=0; Remaining=23)
   819   C2244509:inhibition of cell growth [Cell Function]
   793   C2249823:inhibition of growth [Organism Function]
   789   C0007595:growth of cell [Cell Function]
           Cell Growth
   754   C0431085:Tumor cell [Cell]
   754   C0597032:Tumor Cell [Cell]
   750   C0598934:growth tumor [Neoplastic Process]
   744   C0007634:Cell [Cell]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0027651:Tumors [Neoplastic Process]
   744   C0220844:growth [Physiologic Function]
   744   C0557651:Study [Manufactured Object]
   744   C0947630:studies [Laboratory Procedure]
   744   C1269647:Cell [Cell]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2603343:Study [Research Activity]
   744   C2911660:Growth [Activity]
   744   C3463820:Inhibition [Activity]
   711 E C1578706:Tumor [Intellectual Product]
   711 E C3273930:Tumor [Finding]

Phrase: "by seminal ribonuclease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.281: Cancer Res., 40, 37403744.[Abstract] Youle,R.J. and DAlessio,G. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "37403744."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Youle,"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "DAlessio,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.282: (1997) Antitumor RNases. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Antitumor RNases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.283: In DAlessio,G. and Riordan,J.F. 

Phrase: "In DAlessio,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Riordan,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.284: (eds), Ribonuclease: Structures and Functions. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "Ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "Structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "Functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.285: Academic Press, New York, NY, pp. 

Phrase: "Academic Press,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "pp."
Processing 00000000.tx.286: 491514. 

Phrase: "491514."
Processing 00000000.tx.287: Okabe,Y., Katayama,N., Iwama,M., Watanabe,H., Ohgi,K., Irie,M., Nitta,K., Kawauchi,H., Takayanagi,Y., Oyama,F., Titani,K., Abe,Y., Okazaki,T., Inokuchi,N. and Koyama,T. 

Phrase: "Okabe,"

Phrase: "Y.,"

Phrase: "Katayama,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Iwama,"

Phrase: "M."

Phrase: ","

Phrase: "Watanabe,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ohgi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Irie,"

Phrase: "M."

Phrase: ","

Phrase: "Nitta,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kawauchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takayanagi,"

Phrase: "Y.,"

Phrase: "Oyama,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Titani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Abe,Y.,"

Phrase: "Okazaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Inokuchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Koyama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.288: (1991) Comparative base specificity, stability and lectin activity of two lectins from eggs of Rana catesbeiana and R. japonica and liver ribonuclease from R. catesbeiana. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Comparative base specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "lectin activity of two lectins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1148592:lectin activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "from eggs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0013710:Eggs [Food]
   966 E C0029974:Egg [Cell]
   966 E C1508746:Egg [Organic Chemical,Pharmacologic Substance]

Phrase: "of Rana catesbeiana"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034651:Rana catesbeiana [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: "and"

Phrase: "R. japonica"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1029887:Japonica [Eukaryote]

Phrase: "and"

Phrase: "liver ribonuclease from R. catesbeiana."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0658605:ribonuclease R [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.289: J. 

Phrase: "J."
Processing 00000000.tx.290: Biochem., 109, 786790.[Abstract] Liao,Y.D., Huang,H.C., Chan,H.J. and Kuo,S.J. 

Phrase: "Biochem.,"

Phrase: "109,"

Phrase: "786790."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Liao,"

Phrase: "Y."

Phrase: "D."

Phrase: ","

Phrase: "Huang,"

Phrase: "H.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Chan,"

Phrase: "H.J."

Phrase: "and"

Phrase: "Kuo,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.291: (1996) Large scale preparation of a ribonuclease from Rana catesbeiana (bullfrog) oocytes and characterization of its specific cytotoxicity against tumor cells. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Large scale preparation of a ribonuclease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0455052:Preparation [Health Care Activity]
   753   C1521827:Preparation [Functional Concept]

Phrase: "from Rana catesbeiana"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034651:Rana catesbeiana [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: "(bullfrog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034651:Bullfrog [Amphibian]

Phrase: ")"

Phrase: "oocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029045:Oocytes [Cell]

Phrase: "and"

Phrase: "characterization of its specific cytotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "against tumor cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.292: Protein Expr. 

Phrase: "Protein Expr."
Processing 00000000.tx.293: Purif., 7, 194202.[CrossRef][ISI][Medline] Liao,Y.D., Huang,H.C., Leu,Y.J., Wei,C.W., Tang,P.C. and Wang,S.C. 

Phrase: "Purif.,"

Phrase: "7,"

Phrase: "194202."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liao,"

Phrase: "Y."

Phrase: "D."

Phrase: ","

Phrase: "Huang,"

Phrase: "H.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Leu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Y.J.,"

Phrase: "Wei,"

Phrase: "C.W., Tang,"

Phrase: "P.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Wang,"

Phrase: "S."

Phrase: "C."
Processing 00000000.tx.294: (2000) Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog). 

Phrase: "(2000"

Phrase: ")"

Phrase: "Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "cloning of cytotoxic ribonucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009015:Cloning [Research Activity]

Phrase: "from Rana catesbeiana"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034651:Rana catesbeiana [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: "(bullfrog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034651:Bullfrog [Amphibian]

Phrase: ")."
Processing 00000000.tx.295: Nucleic Acids Res., 28, 40974104.[Abstract/Free FullText] Irie,M., Nitta,K. and Nonaka,T. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "28,"

Phrase: "40974104."

Phrase: "[Abstract/Free FullText"

Phrase: "] Irie,"

Phrase: "M."

Phrase: ","

Phrase: "Nitta,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Nonaka,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.296: (1998) Biochemistry of frog ribonucleases. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry of frog ribonucleases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.297: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.298: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.299: Life Sci., 54, 775784.[CrossRef][ISI][Medline] Chang,C.F., Chen,C., Chen,Y.C., Hom,K., Huang,R.F. and Huang,T.H. 

Phrase: "Life Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]

Phrase: "54,"

Phrase: "775784."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chang,"

Phrase: "C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Y.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Hom,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "R.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Huang,"

Phrase: "T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.300: (1998) The solution structure of a cytotoxic ribonuclease from the oocytes of Rana catesbeiana (bullfrog). 

Phrase: "(1998"

Phrase: ")"

Phrase: "The solution structure of a cytotoxic ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:Structure [Spatial Concept]

Phrase: "from the oocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029045:Oocytes [Cell]

Phrase: "of Rana catesbeiana"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034651:Rana catesbeiana [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: "(bullfrog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034651:Bullfrog [Amphibian]

Phrase: ")."
Processing 00000000.tx.301: J. 

Phrase: "J."
Processing 00000000.tx.302: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.303: Biol., 283, 231244.[CrossRef][ISI][Medline] Huang,H.C., Wang,S.C., Leu,Y.J., Lu,S.C. and Liao,Y.D. 

Phrase: "Biol.,"

Phrase: "283,"

Phrase: "231244."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Huang,"

Phrase: "H.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Wang,"

Phrase: "S."

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Leu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Y.J.,"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "S."

Phrase: "C."

Phrase: "and"

Phrase: "Liao,"

Phrase: "Y.D."
Processing 00000000.tx.304: (1998) The Rana catesbeiana rcr gene encoding a cytotoxic ribonuclease: tissue distribution, cloning, purification, cytotoxicity and active residues for RNase activity. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The Rana catesbeiana rcr gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a cytotoxic ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "tissue distribution,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040287:Tissue Distribution [Quantitative Concept]
  1000   C0220927:tissue distribution [Functional Concept]
   861   C0040300:Tissue [Tissue]
   861   C0520511:distribution [Idea or Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C1704711:Distribution [Functional Concept]

Phrase: "cloning"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]
   966 E C0009013:Clone [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: ","

Phrase: "purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "and"

Phrase: "active residues for RNase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.305: J. 

Phrase: "J."
Processing 00000000.tx.306: Biol. 

Phrase: "Biol."
Processing 00000000.tx.307: Chem., 273, 63956401.[Abstract/Free FullText] Chen,S.L., Le,S.Y., Newton,D.L., Maizel,J.V.,Jr and Rybak,S.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "273,"

Phrase: "63956401."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Le,S.Y.,"

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "D."

Phrase: "L., Maizel,"

Phrase: "J.V.,Jr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Rybak,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.308: (2000) A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3' UTR of unusual length and structure. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A gender-specific mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a cytotoxic ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a 3' UTR of unusual length"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1420099:UTR [Gene or Genome]
   753   C1540171:UTR [Gene or Genome]

Phrase: "and"

Phrase: "structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.309: Nucleic Acids Res., 28, 23752382.[Abstract/Free FullText] Boix,E., Wu,Y.N., Vasandani,V.M., Saxena,S.K., Ardelt,W., Ladner,J. and Youle,R.J. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "28,"

Phrase: "23752382."

Phrase: "[Abstract/Free FullText"

Phrase: "] Boix,"

Phrase: "E.,"

Phrase: "Wu,Y.N., Vasandani,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Saxena,"

Phrase: "S."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ardelt,"

Phrase: "W.,"

Phrase: "Ladner,"

Phrase: "J."

Phrase: "and"

Phrase: "Youle,"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.310: (1996) Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Role of the N terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in RNase A homologues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1334043:Homologue [Gene or Genome]

Phrase: ":"

Phrase: "differences in catalytic activity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "ribonuclease inhibitor interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704675:Interaction [Functional Concept]
   734   C3539761:Ribonuclease Inhibitor [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.311: J. 

Phrase: "J."
Processing 00000000.tx.312: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.313: Biol., 257, 9921007.[CrossRef][ISI][Medline] Liao,Y.D. 

Phrase: "Biol.,"

Phrase: "257,"

Phrase: "9921007."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liao,"

Phrase: "Y.D."
Processing 00000000.tx.314: (1992) A pyrimidine-guanine sequence specific ribonuclease from Rana catesbeiana (bullfrog) oocytes. 

Phrase: "(1992"

Phrase: ")"

Phrase: "A pyrimidine-guanine sequence specific ribonuclease from Rana catesbeiana"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   891   C0298547:pyrimidine-guanine sequence-specific ribonuclease, Rana catesbeiana [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(bullfrog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034651:Bullfrog [Amphibian]

Phrase: ")"

Phrase: "oocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029045:Oocytes [Cell]
Processing 00000000.tx.315: Nucleic Acids Res., 20, 13711377.[Abstract] Liao,Y.D. and Wang,J.J. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "20,"

Phrase: "13711377."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Liao,"

Phrase: "Y.D."

Phrase: "and"

Phrase: "Wang,"

Phrase: "J.J."
Processing 00000000.tx.316: (1994) Yolk granules are the major compartment for bullfrog (Rana catesbeiana) oocyte-specific ribonuclease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Yolk granules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1325693:yolk granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "are"

Phrase: "the major compartment for bullfrog"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "(Rana catesbeiana"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034651:Rana catesbeiana [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: ")"

Phrase: "oocyte-specific ribonuclease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.317: Eur. 

Phrase: "Eur."
Processing 00000000.tx.318: J. 

Phrase: "J."
Processing 00000000.tx.319: Biochem., 222, 215220.[Abstract] Hong,T.H., Chen,S.T., Tang,T.K., Wang,S.C. and Chang,T.H. 

Phrase: "Biochem.,"

Phrase: "222,"

Phrase: "215220."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hong,"

Phrase: "T.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S."

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tang,"

Phrase: "T.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wang,"

Phrase: "S."

Phrase: "C."

Phrase: "and"

Phrase: "Chang,"

Phrase: "T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.320: (1989) The production of polyclonal and monoclonal antibodies in mice using novel immunization methods. 

Phrase: "(1989"

Phrase: ")"

Phrase: "The production of polyclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "monoclonal antibodies in mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   848   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   833   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0746619:monoclonal [Finding]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "novel immunization methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.321: J. 

Phrase: "J."
Processing 00000000.tx.322: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.323: Methods, 120, 151157.[CrossRef][ISI][Medline] Blank,A., Silber,J.R., Thelen,M.P. and Dekker,C.A. 

Phrase: "Methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "120,"

Phrase: "151157."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blank,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750479:blank [Finding]

Phrase: "A.,"

Phrase: "Silber,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Thelen,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Dekker,"

Phrase: "C.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.324: (1983) Detection of enzymatic activities in sodium dodecyl sulfatepolyacrylamide gels: DNA polymerases as model enzymes. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Detection of enzymatic activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   870   C2265875:detection of activity [Molecular Function]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in sodium dodecyl sulfatepolyacrylamide gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: ":"

Phrase: "DNA polymerases as model enzymes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0012892:DNA Polymerases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.325: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.326: Biochem., 135, 423430.[ISI][Medline] Shapiro,R., Riordan,J.F. and Vallee,B.L. 

Phrase: "Biochem.,"

Phrase: "135,"

Phrase: "423430."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shapiro,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Riordan,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Vallee,"

Phrase: "B.L."
Processing 00000000.tx.327: (1986) Characteristic ribonucleolytic activity of human angiogenin. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Characteristic ribonucleolytic activity of human angiogenin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0020115:Human Activity [Activity]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.328: Biochemistry, 25, 35273532.[ISI][Medline] Liao,Y.D. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "25,"

Phrase: "35273532."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liao,"

Phrase: "Y.D."
Processing 00000000.tx.329: (1995) Determination of base specificity of multiple ribonucleases from crude samples. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Determination of base specificity of multiple ribonucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1148554:determination [Laboratory Procedure]

Phrase: "from crude samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.330: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.331: Biol. 

Phrase: "Biol."
Processing 00000000.tx.332: Rep., 20, 149154.[ISI] Russo,N., Acharya,K.R., Vallee,B.L. and Shapiro,R. 

Phrase: "Rep., 20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]

Phrase: "149154."

Phrase: "[ISI] Russo,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Acharya,"

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Vallee,"

Phrase: "B.L."

Phrase: "and"

Phrase: "Shapiro,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.333: (1996) A combined kinetic and modeling study of the catalytic center subsites of human angiogenin. 

Phrase: "(1996"

Phrase: ")"

Phrase: "A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "kinetic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0022702:kinetic [Natural Phenomenon or Process]
   944 E C0026597:Motion [Natural Phenomenon or Process]
   944 E C0687704:Motions [Functional Concept]
   928 E C0022699:Kineses [Individual Behavior]

Phrase: "and"

Phrase: "modeling study of the catalytic center subsites of human angiogenin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0178693:human study [Research Activity]
   739   C0557651:Study [Manufactured Object]
   739   C2603343:Study [Research Activity]
Processing 00000000.tx.334: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.335: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.336: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.337: USA, 93, 804808.[Abstract/Free FullText] Wilkins,M.R., Gasteiger,E., Bairoch,A., Sanchez,J.C., William,K.L., Appel,R.D. and Hochstrsser,D.F. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "93,"

Phrase: "804808."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wilkins,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gasteiger,"

Phrase: "E.,"

Phrase: "Bairoch,"

Phrase: "A.,"

Phrase: "Sanchez,"

Phrase: "J.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "William,"

Phrase: "K.L., Appel,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hochstrsser,"

Phrase: "D."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.338: (1998) Protein identification and analysis tools in the ExPASy Server. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Protein identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020792:Identification [Mental Process]
   861   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "analysis tools in the ExPASy Server."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0336791:Tool [Manufactured Object]
   719   C2827396:Tool [Manufactured Object]
Processing 00000000.tx.339: In Link,A.J. 

Phrase: "In Link,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "A.J."
Processing 00000000.tx.340: (ed.), 2-D Proteome Analysis Protocols. 

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "2-D Proteome Analysis Protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0442711:Protocols [Intellectual Product]
   771 E C1507394:Protocol [Intellectual Product]
   771 E C1522729:Protocol [Intellectual Product]
   771 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.341: Humana Press, New Jersey. 

Phrase: "Humana Press,"

Phrase: "New Jersey."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027971:New Jersey [Geographic Area]
   861   C0205314:New [Temporal Concept]
   861   C0454673:Jersey [Geographic Area]
Processing 00000000.tx.342: Cuchillo,C.M., Vilanova,M. and Nogues,M.V. 

Phrase: "Cuchillo,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Vilanova,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Nogues,"

Phrase: "M."

Phrase: "V."
Processing 00000000.tx.343: (1997) Pancreatic ribonucleases. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Pancreatic ribonucleases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0035541:Pancreatic ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1419407:RIBONUCLEASE, PANCREATIC [Gene or Genome]
   861   C0035542:Ribonucleases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.344: In DAlessio,G. and Riodan,J.F. 

Phrase: "In DAlessio,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Riodan,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.345: (eds), Ribonuclease: Structure and Functions. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "Ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "Functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.346: Academic Press, New York, NY. 

Phrase: "Academic Press,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.347: Raines,R.T. 

Phrase: "Raines,"

Phrase: "R.T."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.348: (1998) Ribonuclease A. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ribonuclease A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.349: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.350: Rev., 98, 10451066.[CrossRef][ISI][Medline] Leu,Y.J., Chen,S.S., Wang,S.C., Hsiao,Y.Y., Amiraslanov,I., Liaw,Y.C. and Liao,Y.D. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "98,"

Phrase: "10451066."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Y.J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "S."

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Hsiao,"

Phrase: "Y.Y.,"

Phrase: "Amiraslanov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liaw,"

Phrase: "Y.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Liao,"

Phrase: "Y.D."
Processing 00000000.tx.351: (2003) Residues involved in the catalysis, base specificity and cytotoxicity of ribonuclease from Rana catesbeiana based upon mutagenesis and X-ray crystallography. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "involved in the catalysis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007382:Catalysis [Natural Phenomenon or Process]
   770   C1314939:Involved [Functional Concept]

Phrase: "base specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "cytotoxicity of ribonuclease"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   718 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   718 E C1511636:cytotoxic [Functional Concept]

Phrase: "from Rana catesbeiana"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034651:Rana catesbeiana [Amphibian]
   861   C0034650:Rana [Amphibian]
   861   C1095816:Rana [Amphibian]

Phrase: "based upon mutagenesis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0079866:Mutagenesis [Molecular Function]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   790   C3146302:Mutagenesis [Laboratory Procedure]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "X-ray crystallography."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0206755:Crystallography, X-Ray [Laboratory Procedure]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0010424:Crystallography [Laboratory Procedure]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C2314876:ray [Fish]
Processing 00000000.tx.352: J. 

Phrase: "J."
Processing 00000000.tx.353: Biol. 

Phrase: "Biol."
Processing 00000000.tx.354: Chem., 278, 73007309.[Abstract/Free FullText] Pruitt,K.D. and Maglott,D.R. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "73007309."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pruitt,"

Phrase: "K.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Maglott,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.355: (2001) RefSeq and LocusLink: NCBI gene-centered resources. 

Phrase: "(2001"

Phrase: ")"

Phrase: "RefSeq"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709876:RefSeq [Intellectual Product]

Phrase: "and"

Phrase: "LocusLink"

Phrase: ":"

Phrase: "NCBI gene-centered resources."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035201:Resources [Idea or Concept]
Processing 00000000.tx.356: Nucleic Acids Res., 29, 137140.[Abstract/Free FullText] Nielsen,H., Brunak,S. and von Heijne,G. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "29,"

Phrase: "137140."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nielsen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Brunak,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "von Heijne,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.357: (1999) Machine learning approaches for the prediction of signal peptides and other protein sorting signals. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Machine learning approaches for the prediction of signal peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449445:Approaches [Spatial Concept]
   742   C1292724:Approaches [Functional Concept]

Phrase: "and"

Phrase: "other protein sorting signals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0887827:Protein Sorting Signals [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1710082:Signal [Phenomenon or Process]
   734   C0887837:Protein Sorting [Cell Function]
Processing 00000000.tx.358: Protein Eng., 12, 39.[Abstract/Free FullText] Busby,W.H.,Jr, Quackenbush,G.E., Humm,J., Youngblood,W.W. and Kizer,J.S. 

Phrase: "Protein Eng.,"

Phrase: "12,"

Phrase: "39."

Phrase: "[Abstract/Free FullText"

Phrase: "] Busby,"

Phrase: "W.H.,Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Quackenbush,"

Phrase: "G.E.,"

Phrase: "Humm,"

Phrase: "J.,"

Phrase: "Youngblood,"

Phrase: "W.W."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709500:%W/W [Quantitative Concept]
  1000   C2919747:w/w [Quantitative Concept]

Phrase: "and"

Phrase: "Kizer,"

Phrase: "J.S."
Processing 00000000.tx.359: (1987) An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. 

Phrase: "(1987"

Phrase: ")"

Phrase: "An enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "("

Phrase: "s)"

Phrase: "that"

Phrase: "converts"

Phrase: "glutaminyl-peptides into pyroglutamyl-peptides."
Processing 00000000.tx.360: J. 

Phrase: "J."
Processing 00000000.tx.361: Biol. 

Phrase: "Biol."
Processing 00000000.tx.362: Chem., 262, 85328536.[Abstract/Free FullText] Fisher,W.H. and Spiess,J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "262,"

Phrase: "85328536."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Spiess,"

Phrase: "J."
Processing 00000000.tx.363: (1987) Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Identification of a mammalian glutaminyl cyclase converting glutaminyl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "into pyroglutamyl peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.364: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.365: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.366: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.367: USA, 84, 36283632.[Abstract] Shapiro,R., Harper,J.W., Fox,E.A., Jansen,H.W., Hein,F. and Uhlmann,E. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "84,"

Phrase: "36283632."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shapiro,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Harper,"

Phrase: "J.W., Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016633:Fox [Mammal]
   755 E C0049564:FOXY [Organic Chemical]

Phrase: "E.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Jansen,"

Phrase: "H.W., Hein,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Uhlmann,"

Phrase: "E."
Processing 00000000.tx.368: (1988) Expression of Met-(-1) angiogenin in Escherichia coli: conversion to the authentic less than Glu-1 protein. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Expression of Met-(-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "angiogenin in Escherichia coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0051844:angiogenin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1367482:ANGIOGENIN [Gene or Genome]

Phrase: ":"

Phrase: "conversion to the authentic less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439836:Conversion [Functional Concept]

Phrase: "than Glu-1 protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.369: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.370: Biochem., 175, 450461.[ISI][Medline] Terzyan,S.S., Peracaula,R., de Llorens,R., Tsushima,Y., Yamada,H., Seno,M., Gomis-Ruth,F.X. and Coll,M. 

Phrase: "Biochem.,"

Phrase: "175,"

Phrase: "450461."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Terzyan,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Peracaula,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "de Llorens,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tsushima,"

Phrase: "Y.,"

Phrase: "Yamada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Seno,"

Phrase: "M."

Phrase: ","

Phrase: "Gomis-Ruth,"

Phrase: "F.X."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Coll,M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.372: The three-dimensional structure of human RNase 4, unliganded and complexed with d(Up), reveals the basis for its uridine selectivity. 

Phrase: "The three-dimensional structure of human RNase 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450363:3-Dimensional [Spatial Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C0678594:Structure [Spatial Concept]

Phrase: "unliganded"

Phrase: "and"

Phrase: "complexed with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "d(Up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the basis for its uridine selectivity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.373: J. 

Phrase: "J."
Processing 00000000.tx.374: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.375: Biol., 285, 205214.[CrossRef][ISI][Medline] Batten,D., Dyer,K.D., Domachowske,J.B. and Rosenberg,H.F. 

Phrase: "Biol.,"

Phrase: "285,"

Phrase: "205214."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Batten,"

Phrase: "D."

Phrase: ","

Phrase: "Dyer,"

Phrase: "K.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Domachowske,"

Phrase: "J.B."

Phrase: "and"

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "H.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.376: (1997) Molecular cloning of four novel murine ribonuclease genes: unusual expansion within the ribonuclease A gene family. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Molecular cloning of four novel murine ribonuclease genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   767   C0598888:cloning genes [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "unusual expansion within the ribonuclease A gene family."
Processing 00000000.tx.377: Nucleic Acids Res., 25, 42354239.[Abstract/Free FullText] Hsu,C.H., Liao,Y.D., Pan,Y.R., Chen,L.W., Wu,S.H., Leu Y.J. and Chen,C.P. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "25,"

Phrase: "42354239."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hsu,"

Phrase: "C.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Liao,"

Phrase: "Y."

Phrase: "D."

Phrase: ","

Phrase: "Pan,Y.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "L.W., Wu,S.H.,"

Phrase: "Leu Y.J."

Phrase: "and"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "C.P."
Processing 00000000.tx.378: (2003) Solution structure of the cytotoxic RNase 4 from oocytes of bullfrog Rana catesbeiana. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Solution structure of the cytotoxic RNase 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:Structure [Spatial Concept]

Phrase: "from oocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029045:Oocytes [Cell]

Phrase: "of bullfrog Rana catesbeiana."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034651:Rana catesbeiana [Amphibian]
   827   C0034650:Rana [Amphibian]
   827   C1095816:Rana [Amphibian]
Processing 00000000.tx.379: J. 

Phrase: "J."
Processing 00000000.tx.380: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.381: Biol., 326, 11891201.[CrossRef][ISI][Medline] Mosimann,S.C., Ardelt,W. and James,M.N. 

Phrase: "Biol.,"

Phrase: "326,"

Phrase: "11891201."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mosimann,"

Phrase: "S."

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Ardelt,"

Phrase: "W."

Phrase: "and"

Phrase: "James,"

Phrase: "M."

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.382: (1994) The refined 1.7? 

Phrase: "(1994"

Phrase: ")"

Phrase: "The refined 1.7?"
Processing 00000000.tx.383: X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity. 

Phrase: "X-ray crystallographic structure of P-30 protein,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   767   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   764   C0206755:Crystallography, X-Ray [Laboratory Procedure]
   744   C0678594:Structure [Spatial Concept]
   731 E C0582263:Structural protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an amphibian ribonuclease with anti-tumor activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1148840:ribonuclease activity [Genetic Function]
   748   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.384: J. 

Phrase: "J."
Processing 00000000.tx.385: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.386: Biol., 236, 11411153.[CrossRef][ISI][Medline] Notomista,E., Catanzano,F., Graziano,G., Gaetano,S.D., Barone,G. and DiDonato,A. 

Phrase: "Biol.,"

Phrase: "236,"

Phrase: "11411153."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Notomista,"

Phrase: "E.,"

Phrase: "Catanzano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Graziano,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Gaetano,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Barone,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "DiDonato,"

Phrase: "A."
Processing 00000000.tx.387: (2001) Contribution of chain termini to the conformation stability and biological activity of onconase. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Contribution of chain termini"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "to the conformation stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "biological activity of onconase."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005532:Biological [Biomedical Occupation or Discipline]
   770   C0205177:Activity [Functional Concept]
   770   C0205460:biological [Qualitative Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.388: Biochemistry, 40, 90979103.[CrossRef][ISI][Medline] Newton,D.L., Boque,L., Wlodawer,A., Huang,C.Y. and Rybak,S.M. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "90979103."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "D."

Phrase: "L., Boque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wlodawer,"

Phrase: "A.,"

Phrase: "Huang,"

Phrase: "C.Y."

Phrase: "and"

Phrase: "Rybak,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.389: (1998) Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biophysical properties. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Single amino acid substitutions at the N-terminus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   711   C1555721:Substitution [Idea or Concept]
   711   C1706204:Substitution [Activity]

Phrase: "of a recombinant cytotoxic ribonuclease markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "influence"

Phrase: "biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "biophysical properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.390: Biochemistry, 37, 51735183.[CrossRef][ISI][Medline] Hirel,P.H., Schmitter,J.M., Dessen,P., Fayat,G. and Blanquet,S. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "37,"

Phrase: "51735183."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hirel,"

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schmitter,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Dessen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fayat,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Blanquet,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.391: (1989) Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Extent of N-terminal methionine excision"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C0449275:Extent of excision [Qualitative Concept]
   753   C0439792:Extent [Spatial Concept]

Phrase: "from Escherichia coli proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0950080:Escherichia coli Proteins [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0014834:Escherichia coli [Bacterium]

Phrase: "is"

Phrase: "governed by the side-chain length of the penultimate amino acid."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C2917660:Amino Acid [Pharmacologic Substance]
   738   C0001128:Acid [Chemical]
   738   C0202406:Acid [Laboratory Procedure]
   738   C0337112:Chain [Manufactured Object]
   738   C0441987:Side [Spatial Concept]
   738   C1444754:Length [Quantitative Concept]
   738   C1524075:Chain [Idea or Concept]
   738   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.392: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.393: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.394: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.395: USA, 86, 82478251.[Abstract] Newton,D.L., Walbridge,S., Mikulski,S.M., Ardelt,W., Shogen,K., Ackerman,S.J., Rybak,S.M. and Youle,R.J. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "86,"

Phrase: "82478251."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "D."

Phrase: "L., Walbridge,"

Phrase: "S."

Phrase: ","

Phrase: "Mikulski,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Ardelt,"

Phrase: "W.,"

Phrase: "Shogen,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ackerman,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Rybak,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Youle,"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.396: (1994) Toxicity of an antitumor ribonuclease to Purkinje neurons. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Toxicity of an antitumor ribonuclease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "to Purkinje neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0034143:Purkinje neuron [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.397: J. 

Phrase: "J."
Processing 00000000.tx.398: Neurosci., 14, 538544.[Abstract] Sorrentino,S., Glitz,D.G., Hamann,K.J., Loegering,D.A., Checkel,J.L. and Gleich,G.J. 

Phrase: "Neurosci.,"

Phrase: "14,"

Phrase: "538544."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sorrentino,"

Phrase: "S."

Phrase: ","

Phrase: "Glitz,"

Phrase: "D."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Hamann,"

Phrase: "K.J.,"

Phrase: "Loegering,"

Phrase: "D."

Phrase: "A.,"

Phrase: "Checkel,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Gleich,"

Phrase: "G.J."
Processing 00000000.tx.399: (1992) Eosinophil-derived neurotoxin and human liver ribonuclease: identity of structure and linkage of neurotoxicity to nuclease activity. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Eosinophil-derived neurotoxin"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0059409:Eosinophil-Derived Neurotoxin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1419408:EOSINOPHIL-DERIVED NEUROTOXIN [Gene or Genome]
   827   C0014467:eosinophil [Cell]
   827   C0027934:Neurotoxin [Hazardous or Poisonous Substance]
   827   C1441547:Derived [Qualitative Concept]
   827   C3245521:derived [Idea or Concept]
   755 E C0333930:Eosinophilic [Functional Concept]
   727 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   727 E C1306759:Eosinophilia [Disease or Syndrome]
   727 E C1636667:Eosinophilia [Disease or Syndrome]
   727 E C2240374:Eosinophilia [Finding]

Phrase: "and"

Phrase: "human liver ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "identity of structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0424215:Identity [Mental Process]
   790   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "linkage of neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023745:linkage [Molecular Function]

Phrase: "to nuclease activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148806:nuclease activity [Genetic Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.400: J. 

Phrase: "J."
Processing 00000000.tx.401: Biol. 

Phrase: "Biol."
Processing 00000000.tx.402: Chem., 267, 1485914865.[Abstract/Free FullText] Rosenberg,H.F. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "267,"

Phrase: "1485914865."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "H.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.403: (1995) Recombinant human eosinophil cationic protein: ribonuclease is not essential for cytotoxicity. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Recombinant human eosinophil cationic protein"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   937   C1312650:eosinophil cationic protein, human [Amino Acid, Peptide, or Protein,Enzyme]
   897   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   884   C0950373:Eosinophil cationic protein [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1419409:EOSINOPHIL CATIONIC PROTEIN [Gene or Genome]
   875   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0014467:eosinophil [Cell]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   733   C0007447:Cation [Chemical Viewed Structurally]
   733 E C0333930:Eosinophilic [Functional Concept]
   704 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   704 E C1306759:Eosinophilia [Disease or Syndrome]
   704 E C1636667:Eosinophilia [Disease or Syndrome]
   704 E C2240374:Eosinophilia [Finding]

Phrase: ":"

Phrase: "ribonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "not essential for cytotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.404: J. 

Phrase: "J."
Processing 00000000.tx.405: Biol. 

Phrase: "Biol."
Processing 00000000.tx.406: Chem., 270, 78767881.[Abstract/Free FullText]

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "270,"

Phrase: "78767881."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

